In vivo partial reprogramming of myofibers promotes muscle regeneration by remodeling the stem cell niche
Open accessAbstract
Short-term, systemic expression of the Yamanaka reprogramming factors ( Oct-3/4 , Sox2 , Klf4 and c-Myc [OSKM]) has been shown to rejuvenate aging cells and promote tissue regeneration in vivo. However, the mechanisms by which OSKM promotes tissue regeneration are unknown. In this work, we focus on a specific tissue and demonstrate that local expression of OSKM, specifically in myofibers, induces the activation of muscle stem cells or satellite cells (SCs), which accelerates muscle regeneration in young mice. In contrast, expressing OSKM directly in SCs does not improve muscle regeneration. Mechanistically, expressing OSKM in myofibers regulates the expression of genes important for the SC microenvironment, including upregulation of p21, which in turn downregulates Wnt4 . This is critical because Wnt4 is secreted by myofibers to maintain SC quiescence. Thus, short-term induction of the Yamanaka factors in myofibers may promote tissue regeneration by modifying the stem cell niche.
AI snapshot
Written from the paper’s full text.
TL;DR
Myofiber-specific, short-term OSKM induction in mice activates satellite cells and accelerates muscle regeneration by inducing p21 and repressing the myofiber-secreted niche factor Wnt4; SC-specific OSKM induction does not improve regeneration. The effect is aging-independent and can be recapitulated by cyclic Wnt4 knockdown.
Key findings
- Myofiber-specific OSKM induction before injury accelerated regeneration: Cre+ muscles had more eMHC+ myofibers at day 3, more Pax7+ cells, larger regenerated myofibers, more Pax7+MyoD+ myoblasts, and higher hindlimb grip strength at day 6; OSKM induction after injury did not accelerate regeneration.
- OSKM in myofibers promoted SC activation/proliferation: Cre+ muscles had a 3-fold higher percentage of Pax7+BrdU+ cells; single Cre+ myofibers had 2-fold more Pax7+ cells and 3-fold more activated MyoD+ SCs, with quiescent MyoD− SCs decreased by half. Self-renewal was maintained after serial injuries.
- SC-specific OSKM induction did not activate/proliferate SCs or improve regeneration; in cultured myoblasts, OSKM inhibited MyoD and miR-133a.
- Mechanistically, Wnt4 was the only niche-related gene downregulated >2-fold; p21 was upregulated, p21 overexpression increased p21 60-fold and downregulated Wnt4 3-fold, ChIP showed 3-fold enrichment at the Wnt4 TATA-proximal region, and p21 inhibited a Wnt4 reporter 2-fold. Cyclic CasRx Wnt4 knockdown (gRNA1: 85% in vitro, 65% in vivo) recapitulated SC activation and regeneration. In 15-month-old mice, Cre+ muscles had 1.8-fold more Pax7+ cells, 2.8-fold more MyoD+ SCs, and 3-fold more BrdU+ SCs.
Methods
- Generated myofiber-specific Acta1-Cre/4Fhet and SC-specific Pax7creER/4Fhet inducible OSKM mouse models; used young (6 weeks–4 months) and aging (12–15 months) mice, both male and female. Doxycycline was given in drinking water (1 mg/ml), often cyclically (2 days on/5 days off), with cardiotoxin injury, BrdU labeling, and tamoxifen for Pax7creER induction.
- Readouts included RNA-seq of EDL/SOL muscles after 2.5 or 8.5 days Dox (DESeq2, WGCNA, GO/GSEA), qPCR, immunostaining/H&E, single myofiber isolation and culture, western blot, ChIP, luciferase assays, and AAV9-CasRx-mediated Wnt4 knockdown.
- Statistical analysis used two-tailed unpaired Student’s t-test with p<0.05; RNA-seq OSKM/niche comparisons used n=2 biological samples, while many histology experiments used n=4–6 mice.
Limitations
- Stated: the authors cannot exclude that other cell types (macrophages, endothelial cells, fibroblasts) or ECM/exosome-mediated indirect effects contribute to SC activation; two possible explanations for maintained SC self-renewal (homeostatic mechanism vs. temporary niche modification) were not distinguished.
- Stated: timing is important—post-injury OSKM did not accelerate regeneration—and systemic vs. myofiber-specific OSKM differ in induction level and p21 induction in SCs.
- Evident: findings are in mice only; key RNA-seq comparisons for OSKM/niche genes used n=2 biological samples; and although both male and female mice were used, sex-specific effects were not analyzed.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 39 cited sources checked · 0 supported · 0 flagged
- Findingreasoning
p21 downregulates Wnt4.
“Mechanistically, expressing OSKM in myofibers regulates the expression of genes important for the SC microenvironment, including upregulation of p21, which in turn downregulates Wnt4.”
Quote in the paperSubstantial claim - Findingown data
Expressing OSKM directly in SCs does not improve muscle regeneration.
“In contrast, expressing OSKM directly in SCs does not improve muscle regeneration.”
Quote in the paperSubstantial claim - Findingown data
Local expression of OSKM specifically in myofibers induces the activation of muscle stem cells or satellite cells (SCs) in young mice.
“In this work, we focus on a specific tissue and demonstrate that local expression of OSKM, specifically in myofibers, induces the activation of muscle stem cells or satellite cells (SCs), which accelerates muscle regeneration in young mice.”
Quote in the paperSubstantial claim - Findingown data
Expressing OSKM in myofibers upregulates p21.
“Mechanistically, expressing OSKM in myofibers regulates the expression of genes important for the SC microenvironment, including upregulation of p21, which in turn downregulates Wnt4.”
Quote in the paperSubstantial claim - Findingown data
Local expression of OSKM specifically in myofibers accelerates muscle regeneration in young mice.
“In this work, we focus on a specific tissue and demonstrate that local expression of OSKM, specifically in myofibers, induces the activation of muscle stem cells or satellite cells (SCs), which accelerates muscle regeneration in young mice.”
Quote in the paperSubstantial claim
- Findingown data
Activated genes were enriched in pathways related to cytoskeleton organization.
“Activated genes were enriched in pathways related to cytoskeleton organization (Supplementary Fig. 2b).”
Quote in the paperNot a substantial claim - Findingown data
OSKM levels were higher in Cre+ EDL muscles compared with Cre− EDL muscles.
“We first sought to confirm OSKM expression, and indeed measured higher levels of OSKM in Cre+ EDL muscles compared with Cre− EDL muscles (Fig. 1c).”
Quote in the paperSubstantial claim - Findingown data
The gene expression level induced or repressed by OSKM was more pronounced in EDL muscles than in SOL muscles.
“As with the PCA analysis, the gene expression level induced or repressed by OSKM was more pronounced in EDL muscles than in SOL muscles (Supplementary Fig. 2a).”
Quote in the paperSubstantial claim - Findingown data
Expression of Oct4, Sox2, and c-Myc was 4-fold higher in Cre+ EDL muscles compared with Cre+ SOL muscles.
“In addition, the expression of Oct4, Sox2, and c-Myc was 4-fold higher in Cre+ EDL muscles compared with Cre+ SOL muscles (baseline expression of these genes was comparable between Cre− EDL and Cre− SOL muscles) (Fig. 1c, d).”
Quote in the paperNot a substantial claim - Findingown data
181 and 202 genes were upregulated and downregulated, respectively, only in the 8.5-day treatment group.
“In contrast, 181 and 202 genes were upregulated and downregulated, respectively, only in the 8.5-day treatment group (Fig. 1h).”
Quote in the paperNot a substantial claim - Findingown data
2.5 and 8.5 days of Dox treatment induced a similar Euclidean distance between the Cre+ and Cre− samples.
“In addition, 2.5 and 8.5 days of Dox treatment induced a similar Euclidean distance between the Cre+ and Cre− samples, consistent with the PCA analysis (Fig. 1e, f).”
Quote in the paperNot a substantial claim - Findingown data
Each of the three modules contained genes repressed or activated by OSKM induction in both EDL and SOL muscles.
“Each of these three modules contained genes repressed or activated by OSKM induction in both EDL and SOL muscles (Supplementary Fig. 2a).”
Quote in the paperNot a substantial claim - Findingown data
More genes were differentially expressed following 2.5 days of OSKM induction than seen following 8.5 days of treatment.
“Interestingly, more genes were differentially expressed following 2.5 days of OSKM induction than seen following 8.5 days of treatment (Fig. 1g).”
Quote in the paperNot a substantial claim - Findingown data
SC-specific OSKM induction does not improve muscle regeneration in young mice.
“In contrast, SC-specific OSKM induction does not improve muscle regeneration in young mice.”
Quote in the paperSubstantial claim - Findingown data
GSEA showed that 2.5 and 8.5 days of treatment affected the same genetic pathways.
“Gene set enrichment analysis (GSEA) showed that 2.5 and 8.5 days of treatment affected the same genetic pathways (Supplementary Fig. 3a).”
Quote in the paperNot a substantial claim - Findingown data
Levels of OSKM upregulation were comparable between 2.5 and 8.5 days of Dox administration.
“First, levels of OSKM upregulation were comparable between 2.5 and 8.5 days of Dox administration (Fig. 1c).”
Quote in the paperNot a substantial claim - Findingown data
Immunostaining verified expression of Sox2 and GFP in EDL muscles of Acta1-Cre+/4Fhet mice but not Acta1-Cre−/4Fhet mice after Dox.
“Immunostaining verified the expression of Sox2 and GFP in extensor digitorum longus (EDL) muscles of Acta1-Cre+/4Fhet mice but not in Acta1-Cre−/4Fhet mice after introduction of Dox (1 mg/ml) in their drinking water for 2.5 days (Supplementary Fig. 1).”
Quote in the paperSubstantial claim - Findingown data
A total of 1142 genes were upregulated and 697 genes were downregulated only in the 2.5-day treatment group.
“A total of 1142 genes were upregulated and 697 genes were downregulated only in the 2.5-day treatment group (Fig. 1h).”
Quote in the paperNot a substantial claim - Findingown data
Repressed genes were enriched for pathways related to metabolism and muscle differentiation.
“The repressed genes were enriched for pathways related to metabolism and muscle differentiation (Supplementary Fig. 2b).”
Quote in the paperNot a substantial claim - Findingown data
The 2.5-day and 8.5-day treatment regimens shared 876 upregulated and 578 downregulated genes.
“The 2.5-day and 8.5-day treatment regimens shared 876 upregulated and 578 downregulated genes (Fig. 1h).”
Quote in the paperNot a substantial claim - Findingreasoning
Co-staining of Pax7 and BrdU did not show a difference in the percentage of Pax7+BrdU+ cells.
“Co-staining of Pax7 and BrdU did not show a difference in the percentage of Pax7+BrdU+ cells, as all SCs entered into the cell cycle at the early stage of regeneration (Fig. 2e).”
Quote in the paperNot a substantial claim - Findingown data
The number of Pax7+MyoD− SCs was comparable in Cre− and Cre+ samples.
“In contrast, the number of Pax7+MyoD− SCs was comparable in Cre− and Cre+ samples (Fig. 2i), indicating Cre+ samples had an expansion of myoblasts without changing the SCs number.”
Quote in the paperSubstantial claim - Findingown data
The percentage of SCs-derived myocytes (MyoD+Pax7−) was comparable between Cre+ and Cre− muscles.
“The percentage of SCs-derived myocytes (MyoD+Pax7−) was comparable between Cre+ and Cre− muscles (Fig. 3d, f).”
Quote in the paperNot a substantial claim - Findingown data
Cre+ samples had more Pax7+MyoD+ myoblasts than Cre− samples.
“Cre+ samples had more Pax7+MyoD+ myoblasts than Cre− samples (Fig. 2i).”
Quote in the paperSubstantial claim - Findingown data
eMHC+ immature myofibers had a smaller myofiber size compared to mature eMHC− myofibers.
“Compared to mature eMHC− myofibers, eMHC+ immature myofibers had a smaller myofiber size (Fig. 2g).”
Quote in the paperNot a substantial claim - Findingown data
Cre+ muscles had more Pax7+ cells than Cre− muscles after cyclic OSKM induction.
“As a consequence, Cre+ muscles had more Pax7+ cells than Cre− muscles (Fig. 3d, e).”
Quote in the paperSubstantial claim - Findingown data
OSKM induction after muscle injury could not accelerate muscle regeneration.
“These data show that OSKM induction after muscle injury could not accelerate muscle regeneration, reinforcing the benefits of preinjury induction of OSKM.”
Quote in the paperSubstantial claim - Findingown data
Cre+ muscles had higher grip strength than Cre− muscles 6 days post CTX treatment.
“Whereas Cre+ and Cre− hind limbs had similarly low grip strength 1 day post CTX injection, Cre+ muscles had higher grip strength than Cre− muscles 6 days post CTX treatment (Fig. 2j), indicating that Cre+ muscles restored their function faster than Cre− muscles.”
Quote in the paperSubstantial claim - Findingown data
Immunostaining confirmed the specific expression of Oct4 in nuclei of myofibers but not in Pax7+ cells after 2 days of Dox treatment.
“Immunostaining confirmed the specific expression of Oct4 in nuclei of myofibers but not in Pax7+ (the SCs marker) cells after 2 days of Dox treatment (Fig. 2b).”
Quote in the paperSubstantial claim - Findingown data
At 6 days post CTX, Cre+ muscles had a lower percentage of eMHC+ regenerating myofibers compared to Cre− muscles.
“Cre+ muscles had a lower percentage of eMHC+ regenerating myofibers compared to Cre− muscles (Fig. 2g), indicating a higher percentage of mature regenerating myofibers in Cre+ muscles.”
Quote in the paperSubstantial claim - Findingown data
Cre+ muscles had a 3-fold higher percentage of Pax7+BrdU+ cells than Cre− muscles after cyclic OSKM induction.
“Co-staining these muscles for BrdU and Pax7 showed that Cre+ muscles had a 3-fold higher percentage of Pax7+BrdU+ cells than Cre− muscles, indicating that myofiber-specific expression of OSKM promoted the proliferation of SCs (Fig. 3b, c).”
Quote in the paperSubstantial claim - Findingown data
Cre+ muscles had more eMHC+ myofibers compared to Cre− muscles at 3 days post CTX.
“Cre+ muscles had more eMHC+ myofibers compared to Cre− muscles (Fig. 2d), indicating an earlier regenerative process in Cre+ muscles.”
Quote in the paperSubstantial claim - Findingown data
There are no eMHC+ myofibers in Cre− and Cre+ muscles before an injury.
“In addition, immunostaining showed that there are no eMHC+ myofibers in Cre− and Cre+ muscles before an injury (Supplementary Fig. 5b), indicating that the activated SCs did not spontaneously contribute to myofibers of Cre+ muscles.”
Quote in the paperSubstantial claim - Findingown data
The number of cell clusters was significantly higher in Cre+ myofibers than Cre− myofibers after 3 days of culture.
“The number of cell clusters was significantly higher in Cre+ myofibers than Cre− myofibers (Fig. 3k, l).”
Quote in the paperSubstantial claim - Findingown data
Fibrosis was similarly low in Cre+ and Cre− muscles at 30 days post-injury.
“Fibrosis was similarly low in Cre+ and Cre− muscles (Fig. 4k), and myofiber sizes were comparable between Cre+ and Cre− muscles (Fig. 4l).”
Quote in the paperNot a substantial claim - Findingown data
Cre+ muscles had more Pax7+ cells compared to Cre− muscles 14 days post CTX injection.
“Co-staining of MyoD and Pax7 showed that Cre+ muscles had more Pax7+ cells compared to Cre− muscles 14 days post CTX injection (Fig. 4b, c).”
Quote in the paperSubstantial claim - Findingown data
All Pax7+ cells expressed MyoD in both Cre− and Cre+ myofibers.
“Additionally, all Pax7+ cells expressed MyoD in both Cre− and Cre+ myofibers (Fig. 3k).”
Quote in the paperNot a substantial claim - Findingown data
The percentage of Pax7+MyoD− SCs was comparable between Cre+ and Cre− muscles 14 days post CTX injection.
“The percentage of Pax7+MyoD− SCs, which are capable of self-renewal was comparable between Cre+ and Cre− muscles (Fig. 4b, c).”
Quote in the paperSubstantial claim - Findingown data
SC doublets were found only in Cre+ myofibers.
“As expected, we found SC doublets, indicative of SC proliferation, only in Cre+ myofibers (Supplementary Fig. 5d).”
Quote in the paperSubstantial claim - Findingown data
Cre+ muscles had a lower percentage of eMHC+ regenerating myofibers compared to Cre− muscles 14 days post CTX injection.
“Cre+ muscles had a lower percentage of eMHC+ regenerating myofibers compared to Cre− muscles (Fig. 4d).”
Quote in the paperNot a substantial claim - Findingown data
At 30 days post the last CTX injury, the number of Pax7+ cells was comparable between Cre+ and Cre− muscles.
“The number of Pax7+ cells was comparable between Cre+ and Cre− muscles (Fig. 5f).”
Quote in the paperSubstantial claim - Findingown data
The number of Pax7+MyoD+ myoblast per cluster was higher in Cre+ myofibers.
“The number of Pax7+MyoD+ myoblast per cluster was higher in Cre+ myofibers (Fig. 3k, m), excluding the possibility that the activated SCs exited the cell cycle for premature differentiation.”
Quote in the paperSubstantial claim - Findingown data
At 7 days after the last CTX injury (day 21) in serial injury, there was no difference in the number of Pax7+ cells between Cre+ and Cre− muscles.
“At 7 days after the last CTX injury (day 21), there was no difference in the number of Pax7+ cells between Cre+ and Cre− muscles (Fig. 5b).”
Quote in the paperSubstantial claim - Findingown data
The percentage of activated (MyoD+) SCs was 3-fold higher in Cre+ myofibers than Cre− myofibers.
“Moreover, the percentage of activated (MyoD+) SCs was 3-fold higher in Cre+ myofibers than Cre− myofibers (Fig. 3h, j).”
Quote in the paperSubstantial claim - Findingown data
Cre+ myofibers were associated with 2-fold more Pax7+ cells than Cre− myofibers.
“Cre+ myofibers were associated with 2-fold more Pax7+ cells than Cre− myofibers (Fig. 3h, i).”
Quote in the paperSubstantial claim - Findingown data
Cre+ muscles had less fibrosis compared to Cre− muscles 14 days post CTX injection.
“Mallory’s trichrome staining showed that the Cre+ muscles had less fibrosis compared to Cre− muscles (Fig. 4e).”
Quote in the paperSubstantial claim - Findingown data
OSKM inhibited the expression of MyoD and miR-133a in SC-derived myoblasts.
“OSKM inhibited the expression of MyoD and miR-133a (Supplementary Fig. 7b), which is consistent with the finding that Oct4 represses the expression of MyoD18.”
Quote in the paperSubstantial claim - Findingown data
Real-time PCR using whole muscle lysates confirmed that OSKM was induced immediately after Dox treatment in Pax7creER/4Fhet mice.
“Real-time PCR using whole muscle lysates confirmed that OSKM was induced immediately after Dox treatment (Supplementary Fig. 6a).”
Quote in the paperSubstantial claim - Findingown data
In 15-month-old myofiber-specific 4F mice, Cre+ muscles had a 3-fold higher percentage of BrdU+ SCs than Cre− muscles.
“Co-staining of BrdU and Pax7 showed that Cre+ muscles had a 3-fold higher percentage of BrdU+ SCs than Cre− muscles (Supplementary Fig. 8e, f).”
Quote in the paperSubstantial claim - Findingown data
The expression level of OSKM in skeletal muscles of systemic 4F mice was 5-10 times lower than that in Acta-Cre/4Fhet mice which were administrated with doxycycline in water.
“The expression level of OSKM in skeletal muscles of systemic 4F mice was 5–10 times lower than that in Acta-Cre/4Fhet mice which were administrated with doxycycline in water (Supplementary Fig. 9e, f).”
Quote in the paperSubstantial claim - Findingown data
In 15-month-old myofiber-specific 4F mice, Cre+ muscles had more SCs than Cre− muscles.
“In addition, Cre+ muscles had more SCs than Cre− muscles (Supplementary Fig. 8j, k).”
Quote in the paperSubstantial claim - Findingown data
The percentage of Pax7+MyoD−BrdU+ SCs was similar in Cre+ and Cre− muscles.
“The percentage of Pax7+MyoD−BrdU+ SCs was also similar in Cre+ and Cre− muscles.”
Quote in the paperSubstantial claim - Findingown data
In 15-month-old myofiber-specific 4F mice, Cre+ muscles had fewer eMHC+ myofibers compared with Cre− muscles 7 days post CTX.
“Cre+ muscles had fewer eMHC+ myofibers compared with Cre− muscles (Supplementary Fig. 8 h, i).”
Quote in the paperSubstantial claim - Findingown data
In 12-15-month-old systemic 4F mice, the percentage of activated (MyoD+) SCs was increased by 1.7-fold.
“We found that the percentage of activated (MyoD+) SCs was increased by 1.7-fold (Supplementary Fig. 9b, c).”
Quote in the paperSubstantial claim - Findingown data
Six days post-injury, no differences in the morphology or size of regenerated myofibers were observed between Cre+ and Cre− muscles in SC-specific OSKM induction.
“Six days post-injury, no differences in the morphology or size of regenerated myofibers were observed between Cre+ and Cre− muscles (Supplementary Fig. 6 h).”
Quote in the paperSubstantial claim - Findingown data
The number of myoblasts in regenerated muscles was comparable between Cre+ and Cre− muscles in SC-specific OSKM induction.
“In addition, the number of myoblasts in regenerated muscles was comparable between Cre+ and Cre− muscles (Supplementary Fig. 6i).”
Quote in the paperSubstantial claim - Findingown data
In 12-15-month-old systemic 4F mice, there was no significant difference in the number of Pax7+ cells as seen in Acta-Cre/4Fhet mice.
“We did not observe a significant difference in the number of Pax7+ cells as seen in Acta-Cre/4Fhet mice (Supplementary Fig. 9b, d).”
Quote in the paperNot a substantial claim - Findingown data
Isolated myofibers cultured for 2 days in Dox induced the expression of OSKM in Cre+ myofibers.
“Isolated myofibers were cultured for 2 days in Dox (1 µg/ml), which induced the expression of OSKM in Cre+ myofibers (Fig. 6d).”
Quote in the paperSubstantial claim - Findingown data
RNA-seq analysis revealed that 2.5 and 8.5 days of Dox treatment affected the expression of 13 niche-related genes in Cre+ muscles.
“RNA-seq analysis revealed that 2.5 and 8.5 days of Dox treatment affected the expression of 13 niche-related genes in Cre+ muscles (Fig. 6a).”
Quote in the paperSubstantial claim - Findingown data
In vivo levels of p53 and p21 protein were increased in Cre+ muscles isolated from Acta1-Cre/4Fhet mice after 2.5 days of Dox treatment.
“Consistent with this, in vivo levels of p53 and p21 protein were increased in Cre+ muscles isolated from Acta1-Cre/4Fhet mice after 2.5 days of Dox treatment (Fig. 6f).”
Quote in the paperSubstantial claim - Findingown data
3xFLAG-p21 enriches the TATA-proximal region of the Wnt4 promoter as determined by ChIP assay.
“h Enrichments of the TATA-proximal region of the Wnt4 promoter by 3xFLAG-p21 as determined by ChIP assay using an antibody against FLAG.”
Quote in the paperSubstantial claim - Findingown data
Levels of p21 expression were negatively correlated with Wnt4 expression in our RNA-seq analysis.
“In mouse keratinocytes, p21 inhibits Wnt4 expression by binding to the TATA-proximal region of the Wnt4 promoter in association with E2F transcription factor 1 (E2F-1)24, and levels of p21 expression were negatively correlated with Wnt4 expression in our RNA-seq analysis (Fig. 6b).”
Quote in the paperSubstantial claim - Findingown data
The ChIP assay showed a 3-fold enrichment of the TATA-proximal region of the Wnt4 promoter in TA muscles with p21 overexpression.
“The ChIP assay showed a 3-fold enrichment of the TATA-proximal region in muscles with p21 overexpression (Fig. 6h).”
Quote in the paperSubstantial claim - Findingown data
rWnt4 significantly decreased the expression of MyoD in Pax7+ cells from Cre+ myofibers 8 h after treatment.
“rWnt4 significantly decreased the expression of MyoD and abolished the upregulation of active Yap in Pax7+ cells from Cre+ myofibers 8 h after treatment (Supplementary Fig. 10d–f).”
Quote in the paperSubstantial claim - Findingown data
rWnt4 treatment abrogated the increase in Pax7+ cells per cluster in Cre+ myofibers.
“More Pax7+ cells per cluster were found in Cre+ myofibers compared to Cre− myofibers 48 h after treatment, which was abrogated by rWnt4 treatment (Supplementary Fig. 10g).”
Quote in the paperSubstantial claim - Findingown data
Wnt4 expression was decreased by 65% in left TA muscles compared to right TA muscles following Dox treatment.
“we verified that Wnt4 expression was decreased by 65% in left TA muscles compared to right TA muscles following Dox treatment, and returned to control levels following Dox withdrawal (Fig. 7b).”
Quote in the paperSubstantial claim - Findingown data
All three gRNAs could efficiently diminish the mCherry signal.
“Our results showed that all three gRNAs could efficiently diminish the mCherry signal (Supplementary Fig. 11a).”
Quote in the paperSubstantial claim - Findingown data
The percentage of Pax7+MyoD+ active Yap+ cells was 3-fold higher in Cre+ myofibers than in Cre− myofibers.
“the percentage of Pax7+MyoD+ active Yap+ cells was 3-fold higher in Cre+ myofibers than in Cre− myofibers (Supplementary Fig. 10b).”
Quote in the paperSubstantial claim - Findingown data
rWnt4 did not change the expression of active Yap and MyoD in Pax7+ cells from Cre− myofibers.
“rWnt4 did not change the expression of active Yap and MyoD in Pax7+ cells from Cre− myofibers”
Quote in the paperNot a substantial claim - Findingown data
KD muscles had more myofibers that were 30-40 μm in diameter than control muscles.
“myofibers in KD muscles were larger than those observed in control, with more myofibers that were 30–40 µm and less that were 10–20 µm in diameter (Fig. 7i).”
Quote in the paperNot a substantial claim - Findingown data
p21 inhibited the PWnt4−Pmin-Luc reporter by 2-fold.
“p21 inhibited the PWnt4−Pmin-Luc reporter by 2-fold (Fig. 6i).”
Quote in the paperSubstantial claim - Findingown data
p21 was unable to affect the control reporter Pmin-Luc, which lacks the TATA-proximal region.
“Whereas p21 was unable to affect the control reporter (Pmin-Luc), which lacks the TATA-proximal region”
Quote in the paperSubstantial claim - Findingown data
KD muscles had more Pax7+MyoD+ myoblasts than control muscles.
“KD muscles had more Pax7+MyoD+ myoblasts than control muscles (Fig. 7h).”
Quote in the paperSubstantial claim - Findingown data
KD muscles had 3-fold more activated (MyoD+) SCs than control muscles.
“KD muscles had 2-fold more Pax7+ cells and 3-fold more activated (MyoD+) SCs than control muscles (Fig. 7e).”
Quote in the paperSubstantial claim - Findingown data
Levels of active Yap were higher in Pax7+ cells from Cre+ myofibers than in Pax7+ cells from Cre− myofibers.
“levels of active Yap were higher in Pax7+ cells from Cre+ myofibers than in Pax7+ cells from Cre− myofibers (Supplementary Fig. 10a, b).”
Quote in the paperSubstantial claim - Findingown data
The number of Pax7+MyoD− SCs was comparable in control and KD samples.
“the number of Pax7+MyoD− SCs was comparable in control and KD samples (Fig. 2i)”
Quote in the paperSubstantial claim - Findingown data
KD muscles had 1-fold less eMHC+ myofibers compared with control muscles.
“KD muscles had 1-fold less eMHC+ myofibers compared with control muscles (Fig. 7g).”
Quote in the paperSubstantial claim - Findingown data
Myofibers in KD muscles were larger than those observed in control muscles.
“myofibers in KD muscles were larger than those observed in control, with more myofibers that were 30–40 µm and less that were 10–20 µm in diameter (Fig. 7i).”
Quote in the paperNot a substantial claim - Findingown data
KD muscles had 2-fold more Pax7+ cells than control muscles.
“KD muscles had 2-fold more Pax7+ cells and 3-fold more activated (MyoD+) SCs than control muscles (Fig. 7e).”
Quote in the paperSubstantial claim - Findingown data
There was no enrichment of the TATA-proximal region in control muscles.
“In contrast, there was no enrichment of the TATA-proximal region in control muscles (Fig. 6h).”
Quote in the paperSubstantial claim - Findingown data
Wnt4 expression returned to control levels following Dox withdrawal.
“we verified that Wnt4 expression was decreased by 65% in left TA muscles compared to right TA muscles following Dox treatment, and returned to control levels following Dox withdrawal (Fig. 7b).”
Quote in the paperNot a substantial claim - Findingown data
gRNA1 decreased the expression of Wnt4 by 85% compared with mock gRNA.
“gRNA1 decreased the expression of Wnt4 by 85%, and both gRNA2 and gRNA3 decreased the expression of Wnt4 by around 75% compared with mock gRNA (Supplementary Fig. 11b).”
Quote in the paperNot a substantial claim - Findingown data
Left muscles with AAV-gRNA1-CasRx (KD) had a 3-fold higher percentage of Pax7+BrdU+ cells than right control muscles.
“left muscles (with AAV-gRNA1-CasRx, KD) had a 3-fold higher percentage of Pax7+BrdU+cells than right (with AAV-CasRx, control) (Fig. 7d).”
Quote in the paperSubstantial claim - Findingown data
rWnt4 abolished the upregulation of active Yap in Pax7+ cells from Cre+ myofibers 8 h after treatment.
“rWnt4 significantly decreased the expression of MyoD and abolished the upregulation of active Yap in Pax7+ cells from Cre+ myofibers 8 h after treatment (Supplementary Fig. 10d–f).”
Quote in the paperSubstantial claim - Findingown data
KD muscles had fewer myofibers that were 10-20 μm in diameter than control muscles.
“myofibers in KD muscles were larger than those observed in control, with more myofibers that were 30–40 µm and less that were 10–20 µm in diameter (Fig. 7i).”
Quote in the paperNot a substantial claim - Findingown data
gRNA2 and gRNA3 decreased the expression of Wnt4 by around 75% compared with mock gRNA.
“gRNA1 decreased the expression of Wnt4 by 85%, and both gRNA2 and gRNA3 decreased the expression of Wnt4 by around 75% compared with mock gRNA (Supplementary Fig. 11b).”
Quote in the paperNot a substantial claim - Findingown data
More Pax7+ cells per cluster were found in Cre+ myofibers compared to Cre− myofibers 48 h after treatment.
“More Pax7+ cells per cluster were found in Cre+ myofibers compared to Cre− myofibers 48 h after treatment, which was abrogated by rWnt4 treatment (Supplementary Fig. 10g).”
Quote in the paperSubstantial claim - Findingreasoning
The effect of OSKM on SC activation and proliferation was negligible after injury.
“As injury is a strong signal to trigger SC proliferation, the effect of OSKM on SC activation and proliferation was negligible after injury, and thus post-injury induction of OSKM did not accelerate muscle regeneration.”
Quote in the paperSubstantial claim - Findingown data
Systemic OSKM induction did not change the number of Pax7+ cells in naturally aging mice after 3 weeks of cyclic induction of OSKM.
“In contrast, systemic OSKM induction did not change the number of Pax7+ cells in naturally aging mice after 3 weeks of cyclic induction of OSKM.”
Quote in the paperNot a substantial claim - Findingreasoning
Post-injury induction of OSKM did not accelerate muscle regeneration.
“As injury is a strong signal to trigger SC proliferation, the effect of OSKM on SC activation and proliferation was negligible after injury, and thus post-injury induction of OSKM did not accelerate muscle regeneration.”
Quote in the paperSubstantial claim - Findingown data
No difference in muscle regeneration was observed with SC-specific OSKM induction.
“In addition, SC-specific OSKM induction did not change the quantity of SCs or myoblasts and thus no difference in muscle regeneration was observed.”
Quote in the paperSubstantial claim - Findingown data
SC-specific OSKM induction did not change the quantity of SCs or myoblasts.
“In addition, SC-specific OSKM induction did not change the quantity of SCs or myoblasts and thus no difference in muscle regeneration was observed.”
Quote in the paperSubstantial claim - Findingown data
In our model, the myofiber-specific OSKM induction did not change the number and state of SCs after multiple muscle injuries.
“In our model, the myofiber-specific OSKM induction did not change the number and state of SCs after multiple muscle injuries.”
Quote in the paperSubstantial claim - Premisecitation
Reprogramming factors promote tissue regeneration in aged mice.
“Besides amelioration of cellular aging hallmarks, reprogramming factors promote tissue regeneration in aged mice8,10.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [8] Ocampo, A. et al. In vivo amelioration of age-associated hallmarks by partial reprogramming. Cell 167, e1712 (2016). 1719-1733. source
Not checked in the free run.
- cites [10] Lu, Y. et al. Reprogramming to recover youthful epigenetic information and restore vision. Nature 588, 124–129 (2020). source
Not checked in the free run.
- Premisecitation
Reprogramming in vivo induces tumor development.
“However, reprogramming in vivo induces tumor development5–7.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [5] Abad, M. et al. Reprogramming in vivo produces teratomas and iPS cells with totipotency features. Nature 502, 340–345 (2013). source
Not checked in the free run.
- cites [6] Ohnishi, K. et al. Premature termination of reprogramming in vivo leads to cancer development through altered epigenetic regulation. Cell 156, 663–677 (2014). source
Not checked in the free run.
- cites [7] Shibata, H. et al. In vivo reprogramming drives Kras-induced cancer development. Nat. Commun. 9, 2081 (2018). source
Not checked in the free run.
- Interpretationreasoning
Short-term induction of the Yamanaka factors in myofibers may promote tissue regeneration by modifying the stem cell niche.
“Thus, short-term induction of the Yamanaka factors in myofibers may promote tissue regeneration by modifying the stem cell niche.”
Quote in the paperSubstantial claim - Premisecitation
Wnt4 is secreted by myofibers to maintain SC quiescence.
“This is critical because Wnt4 is secreted by myofibers to maintain SC quiescence.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [23] Eliazer, S. et al. Wnt4 from the niche controls the mechano-properties and quiescent state of muscle stem cells. Cell Stem Cell 25, 654–665.e4 (2019). source
Not checked in the free run.
- Interpretationown data
Myofiber-specific OSKM induction accelerates muscle regeneration through downregulating the myofiber-secreted niche factor Wnt4, to induce the activation and proliferation of SCs.
“Our data shows that myofiber-specific OSKM induction accelerates muscle regeneration through downregulating the myofiber-secreted niche factor, Wnt4, to induce the activation and proliferation of SCs.”
Quote in the paperSubstantial claim - Premisecitation
Partial reprogramming promotes skeletal muscle regeneration in 12-month-old mice.
“We have shown that partial reprogramming promotes skeletal muscle regeneration in 12-month-old mice8, but these studies were performed by expressing OSKM systemically (i.e., in all cell types)8.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [8] Ocampo, A. et al. In vivo amelioration of age-associated hallmarks by partial reprogramming. Cell 167, e1712 (2016). 1719-1733. source
Not checked in the free run.
- Interpretationown data
OSKM was more strongly induced in fast-twitch muscles than in slow-twitch muscles.
“These results indicate that OSKM was more strongly induced in fast-twitch muscles than in slow-twitch muscles.”
Quote in the paperNot a substantial claim - Interpretationown data
Cre+ muscles restored their function faster than Cre− muscles.
“Whereas Cre+ and Cre− hind limbs had similarly low grip strength 1 day post CTX injection, Cre+ muscles had higher grip strength than Cre− muscles 6 days post CTX treatment (Fig. 2j), indicating that Cre+ muscles restored their function faster than Cre− muscles.”
Quote in the paperSubstantial claim - Interpretationown data
Pax7+ cells were not derived from myofibers.
“All the Pax7+ cells were Td−, indicating that Pax7+ cells were not derived from myofibers (Supplementary Fig. 5c).”
Quote in the paperSubstantial claim - Interpretationown data
Activated SCs did not spontaneously contribute to myofibers of Cre+ muscles.
“In addition, immunostaining showed that there are no eMHC+ myofibers in Cre− and Cre+ muscles before an injury (Supplementary Fig. 5b), indicating that the activated SCs did not spontaneously contribute to myofibers of Cre+ muscles.”
Quote in the paperSubstantial claim - Interpretationown data
Preinjury induction of OSKM is beneficial for accelerating muscle regeneration.
“These data show that OSKM induction after muscle injury could not accelerate muscle regeneration, reinforcing the benefits of preinjury induction of OSKM.”
Quote in the paperSubstantial claim - Interpretationown data
Partial reprogramming of myofibers accelerated muscle regeneration.
“These results suggest that partial reprogramming of myofibers accelerated muscle regeneration.”
Quote in the paperSubstantial claim - Interpretationown data
Activated SCs did not exit the cell cycle for premature differentiation.
“The number of Pax7+MyoD+ myoblast per cluster was higher in Cre+ myofibers (Fig. 3k, m), excluding the possibility that the activated SCs exited the cell cycle for premature differentiation.”
Quote in the paperSubstantial claim - Interpretationown data
Myofiber-specific OSKM induction accelerated muscle regeneration.
“These results further confirm that myofiber-specific OSKM induction accelerated muscle regeneration.”
Quote in the paperSubstantial claim - Interpretationown data
The SC pool was maintained after OSKM induction.
“These results show that the SC pool was maintained after OSKM induction.”
Quote in the paperSubstantial claim - Interpretationown data
Myofiber-specific OSKM induction did not change the self-renewal capacity of SCs.
“Together, these data prove that myofiber-specific OSKM induction did not change the self-renewal capacity of SCs.”
Quote in the paperSubstantial claim - Premisecitation
Induction of p21 could negatively regulate the G1 to S progression of satellite cells.
“The induction of p21 could negatively regulate the G1 to S progression of satellite cells19.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [19] McCroskery, S., Thomas, M., Maxwell, L., Sharma, M. & Kambadur, R. Myostatin negatively regulates satellite cell activation and self-renewal. J. Cell Biol. 162, 1135–1147 (2003). source
Not checked in the free run.
- Interpretationown data
SC-specific OSKM induction did not lead to the activation and proliferation of SCs.
“The number of Pax7+ cells, as well as the percentages of MyoD+ and BrdU+ SCs were all comparable between Cre+ and Cre− muscles (Supplementary Fig. 6e–g), indicating that SC-specific OSKM induction did not lead to the activation and proliferation of SCs.”
Quote in the paperSubstantial claim - Interpretationreasoning
The results provide an additional explanation for the improved muscle regeneration in systemic 4F mice besides SC rejuvenation.
“Our results provide an additional explanation for the improved muscle regeneration in systemic 4F mice besides SC rejuvenation.”
Quote in the paperSubstantial claim - Premisecitation
Systemic OSKM induction could promote muscle regeneration in 12-month-old systemic 4F mice.
“We previously showed that systemic OSKM induction could promote muscle regeneration in 12-month-old systemic 4F mice8.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [8] Ocampo, A. et al. In vivo amelioration of age-associated hallmarks by partial reprogramming. Cell 167, e1712 (2016). 1719-1733. source
Not checked in the free run.
- Interpretationown data
Cyclic induction of OSKM in young SCs did not improve muscle regeneration.
“Based on these observations, we conclude that the cyclic induction of OSKM in young SCs did not improve muscle regeneration.”
Quote in the paperSubstantial claim - Premisecitation
OSKM induction activates the p53-p21 pathway.
“It is known that OSKM induction activates the p53–p21 pathway25.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [25] Hong, H. et al. Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature 460, 1132–1135 (2009). source
Not checked in the free run.
- Premisecitation
Wnt4 is a recently identified paracrine factor that is secreted from myofibers.
“Wnt family member 4 (Wnt4) is a recently identified paracrine factor that is secreted from myofibers23.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [23] Eliazer, S. et al. Wnt4 from the niche controls the mechano-properties and quiescent state of muscle stem cells. Cell Stem Cell 25, 654–665.e4 (2019). source
Not checked in the free run.
- Interpretationown data
OSKM in myofibers inhibits Wnt4 expression through p21.
“OSKM in myofibers inhibits Wnt4 expression through p21”
Quote in the paperSubstantial claim - Interpretationown data
Expressing OSKM in myofibers induced p53-p21 signaling, which subsequently inhibited Wnt4 transcription.
“Specifically, expressing OSKM in myofibers induced p53–p21 signaling, which subsequently inhibited Wnt4 transcription.”
Quote in the paperSubstantial claim - Interpretationown data
Cyclic Wnt4 knockdown recapitulated OSKM induction to induce SC activation and myoblast expansion to promote muscle regeneration.
“Together, these results indicate that cyclic Wnt4 knockdown recapitulated OSKM induction to induce SC activation and myoblasts expansion to promote muscle regeneration.”
Quote in the paperSubstantial claim - Interpretationown data
Partial reprogramming via OSKM can remodel a stem cell niche to induce stem cell activation and proliferation and accelerate muscle regeneration.
“Our work demonstrates that partial reprogramming via OSKM can remodel a stem cell niche to induce stem cell activation and proliferation and accelerate muscle regeneration.”
Quote in the paperSubstantial claim - Interpretationown data
OSKM induction downregulated the expression of Wnt4 through p21.
“These results prove that OSKM induction downregulated the expression of Wnt4 through p21.”
Quote in the paperSubstantial claim - Interpretationown data
The repression of Wnt4 was responsible for OSKM induction-induced SC activation and proliferation by activating MyoD and Yap.
“These results indicate that the repression of Wnt4 was responsible for OSKM induction-induced SCs activation and proliferation by activating MyoD and Yap.”
Quote in the paperSubstantial claim - Premisecitation
The activation kinetics of SCs is delayed in aged SCs.
“SCs activation is required for muscle regeneration, but the activation kinetics is delayed in aged SCs30.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [30] Kimmel J. C., Hwang A. B., Scaramozza A., Marshall W. F., Brack A. S. Aging induces aberrant state transition kinetics in murine muscle stem cells. Development 147, dev183855 (2020). source
Not checked in the free run.
- Interpretationreasoning
The downregulation of Wnt4 contributed to the activation of MyoD and Yap in SCs, resulting in their proliferation.
“The downregulation of Wnt4 contributed to the activation of MyoD and Yap in SCs, resulting in their proliferation.”
Quote in the paperSubstantial claim - Premisecitation
Systemic OSKM induction has been shown to mitigate the decline of Pax7+ cells in progeria mice after 6 weeks of cyclic induction of OSKM.
“Systemic OSKM induction has been shown to mitigate the decline of Pax7+ cells in progeria mice after 6 weeks of cyclic induction of OSKM8.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [8] Ocampo, A. et al. In vivo amelioration of age-associated hallmarks by partial reprogramming. Cell 167, e1712 (2016). 1719-1733. source
Not checked in the free run.
- Interpretationreasoning
Modifying the stem cell niche could be a definitive intervention to boost young tissue regeneration.
“Our results suggest that modifying the stem cell niche could be a definitive intervention to boost young tissue regeneration.”
Quote in the paperSubstantial claim- Rests on an assumption: The intrinsic regulatory machinery is efficient in young SCs.
- Premisecitation
Diminishment of the SC pool is not observed when SCs-SC niche molecular interactions are interrupted in muscles lacking Wnt4, N-, and M-cadherins or syndecan-3.
“Interestingly, diminishment of the SC pool is not observed when SCs-SC niche molecular interactions are interrupted in muscles lacking Wnt4, N-, and M-cadherins or syndecan-323,39,40.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [23] Eliazer, S. et al. Wnt4 from the niche controls the mechano-properties and quiescent state of muscle stem cells. Cell Stem Cell 25, 654–665.e4 (2019). source
Not checked in the free run.
- cites [39] Goel, A. J., Rieder, M. K., Arnold, H. H., Radice, G. L. & Krauss, R. S. Niche cadherins control the quiescence-to-activation transition in muscle stem cells. Cell Rep. 21, 2236–2250 (2017). source
Not checked in the free run.
- cites [40] Pisconti, A. et al. Loss of niche-satellite cell interactions in syndecan-3 null mice alters muscle progenitor cell homeostasis improving muscle regeneration. Skelet. Muscle 6, 34 (2016). source
Not checked in the free run.
- Interpretationreasoning
Further improvement of SC quality is limited.
“The intrinsic regulatory machinery is efficient in young SCs, therefore, further improvement of SC quality is limited.”
Quote in the paperSubstantial claim- Rests on an assumption: The intrinsic regulatory machinery is efficient in young SCs.
- Interpretationcitation
The effect of cyclic Wnt4 knockdown on muscle regeneration is similar to permanent Wnt4 knockdown.
“Interestingly, the effect of cyclic Wnt4 knockdown on muscle regeneration is similar to permanent Wnt4 knockdown23.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [23] Eliazer, S. et al. Wnt4 from the niche controls the mechano-properties and quiescent state of muscle stem cells. Cell Stem Cell 25, 654–665.e4 (2019). source
Not checked in the free run.
- Interpretationown data
Wnt4 is a downstream target of OSKM.
“We identified Wnt4 as a downstream target of OSKM and found that cyclic Wnt4 knockdown could facilitate SC activation and muscle regeneration.”
Quote in the paperSubstantial claim - Interpretationown data
Cyclic Wnt4 knockdown facilitates SC activation and muscle regeneration.
“We identified Wnt4 as a downstream target of OSKM and found that cyclic Wnt4 knockdown could facilitate SC activation and muscle regeneration.”
Quote in the paperSubstantial claim
- May combine two claims. 35
- Classified as probably not a substantial claim. 16
- The quote only partly states this claim. 2
May combine two claims.
Findingown dataPCA of the RNA-seq data revealed a clear separation between Cre+ and Cre− samples, and the separation distance was wider in EDL muscles than in SOL muscles.
“Principal component analysis (PCA) of the RNA-seq data revealed a clear separation between Cre+ and Cre− samples, and the separation distance was wider in EDL muscles than in SOL muscles (Fig. 1e), consistent with the levels of OSKM induction.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn SOL muscles, Oct4, Sox2, and c-Myc were induced, but Klf4 expression was similar between Cre+ and Cre− SOL muscles.
“In SOL muscles, however, Oct4, Sox2, and c-Myc were induced, but the expression of Klf4 was similar between Cre+ and Cre− SOL muscles (Fig. 1d).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataDE genes resulting from 2.5 or 8.5 days of treatment had similar distribution patterns when visualized using volcano plots.
“Furthermore, DE genes resulting from 2.5 or 8.5 days of treatment had similar distribution patterns when visualized using volcano plots (Fig. 1g).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataEleven modules were identified, but only three were enriched for GO terms associated with biological processes.
“Eleven modules were identified, but only three were enriched for GO terms associated with biological processes (Supplementary Fig. 2a, b).”
Quote in the paperNot a substantial claimThe quote only partly states this claim.
Findingown dataCre+ samples had more Pax7+ cells than Cre− samples at 3 days post CTX.
“In addition, Cre+ samples had more Pax7+ cells than Cre− samples (Fig. 2e).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataCre+ muscles had a higher percentage of activated (MyoD+) SCs and a lower percentage of quiescent (MyoD−) SCs than Cre− muscles.
“Co-staining for Pax7 and MyoD showed that Cre+ muscles had a higher percentage of activated (MyoD+) SCs and a lower percentage of quiescent (MyoD−) SCs than Cre− muscles (Fig. 3d, f).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataH&E staining did not reveal any morphological differences between Cre+ and Cre− muscle sections and the myofibers in Cre− and Cre+ muscles lacked central nuclei.
“H&E staining did not reveal any morphological differences between Cre+ and Cre− muscle sections and the myofibers in Cre− and Cre+ muscles lacked central nuclei (Supplementary Fig. 5a).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe GO biological process term most enriched in shared upregulated genes was related to cytoskeleton organization, whereas downregulated genes were related to oxidative phosphorylation.
“The GO biological process term most enriched in these upregulated genes was related to cytoskeleton organization, whereas downregulated genes were related to oxidative phosphorylation (Fig. 1h).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataOSKM expression was induced in the TA muscle following 2 days of Dox treatment, with OSKM levels returning back to control levels following 5 days of withdrawal.
“OSKM expression was induced in the TA muscle following 2 days of Dox treatment, with OSKM levels returning back to control levels following 5 days of withdrawal (Fig. 2a).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataThe 202 downregulated genes were enriched in GO biological process terms related to cellular response to stimulus, whereas the 181 upregulated genes were not enriched for a specific GO biological process term.
“These 202 downregulated genes were enriched in GO biological process terms related to cellular response to stimulus (Supplementary Fig. 3b), whereas the 181 upregulated genes were not enriched for a specific GO biological process term.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataRegenerated myofibers in Cre+ muscles were larger than those observed in Cre− muscles, with more myofibers that were 30-40 μm and fewer that were 10-20 μm in diameter.
“Consistently, regenerated myofibers in Cre+ muscles were larger than those observed in Cre− muscles, with more myofibers that were 30–40 µm and fewer that were 10–20 µm in diameter (Fig. 2h).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAt 30 days post-injury, the number of Pax7+ cells and the percentage of Pax7+MyoD− SCs were comparable between Cre+ and Cre− muscles.
“At 30 days post-injury, the number of Pax7+ cells and the percentage of Pax7+MyoD− SCs were comparable between Cre+ and Cre− muscles (Fig. 4h, i).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataMuscle structure was restored and there were no eMHC+ myofibers in Cre+ and Cre− muscles at 30 days post-injury.
“Muscle structure was restored and there were no eMHC+ myofibers in Cre+ and Cre− muscles (Fig. 4j).”
Quote in the paperNot a substantial claimThe quote only partly states this claim.
Findingown dataMyofiber sizes were comparable between Cre+ and Cre− muscles at 30 days post-injury.
“Fibrosis was similarly low in Cre+ and Cre− muscles (Fig. 4k), and myofiber sizes were comparable between Cre+ and Cre− muscles (Fig. 4l).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe percentage of eMHC+ regenerating myofibers and myofiber sizes were comparable between Cre+ and Cre− muscles after serial injury.
“The percentage of eMHC+ regenerating myofibers and myofiber sizes were comparable between Cre+ and Cre− muscles (Fig. 5c, d).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataRegenerated myofibers in Cre+ muscles were larger than those observed in Cre− muscle, with more myofibers that were 50-60 μm in diameter.
“In addition, regenerated myofibers in Cre+ muscles were larger than those observed in Cre− muscle, with more myofibers that were 50–60 µm in diameter (Fig. 4f).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe percentage of quiescent (MyoD−) SCs was decreased by half in Cre+ myofibers compared to Cre− myofibers, and there was no difference in the percentage of MyoD+Pax7− cells.
“Conversely, the percentage of quiescent (MyoD−) SCs was decreased by half in Cre+ myofibers compared to Cre− myofibers, and there was no difference in the percentage of MyoD+Pax7− cells (Fig. 3h, j).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown datap21 was induced in the SCs of systemic 4F muscles but not in the SCs of Acta-Cre/4Fhet mice.
“In addition, p21 was induced in the SCs of systemic 4F muscles but not in the SCs of Acta-Cre/4Fhet mice (Supplementary Fig. 9 g).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn 15-month-old myofiber-specific 4F mice, Cre+ muscles had 1.8-fold more Pax7+ cells and 2.8-fold more activated (MyoD+) SCs than Cre− muscles.
“Cre+ muscles had 1.8-fold more Pax7+ cells and 2.8-fold more activated (MyoD+) SCs than Cre− muscles (Supplementary Fig. 8b-d).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn 15-month-old myofiber-specific 4F mice, myofibers in Cre+ muscles were larger than those observed in Cre− muscle, with more myofibers that were 30-40 μm and fewer myofibers that were 10-20 μm in diameter.
“Moreover, myofibers in Cre+ muscles were larger than those observed in Cre− muscle, with more myofibers that were 30–40 µm and fewer myofibers that were 10–20 µm in diameter (Supplementary Fig. 8 l).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn SC-specific OSKM induction, the number of Pax7+ cells, as well as the percentages of MyoD+ and BrdU+ SCs, were all comparable between Cre+ and Cre− muscles.
“The number of Pax7+ cells, as well as the percentages of MyoD+ and BrdU+ SCs were all comparable between Cre+ and Cre− muscles (Supplementary Fig. 6e–g), indicating that SC-specific OSKM induction did not lead to the activation and proliferation of SCs.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataExpression of four genes (Itga7, Sdc4, Wnt2b, and Wnt4) was altered on average over two-fold, and among these, Wnt4 was the only one that was downregulated.
“Expression of four of these genes (Itga7, Sdc4, Wnt2b, and Wnt4) was altered on average over two-fold, and among these, Wnt4 was the only one that was downregulated (Fig. 6a).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataElectroporation of the CAG-3xFLAG-p21 plasmid increased p21 expression 60-fold and downregulated Wnt4 levels 3-fold compared with the control plasmid (CAG-Td).
“Electroporation of the CAG-3xFLAG-p21 plasmid increased p21 expression 60-fold, and downregulated Wnt4 levels 3-fold, compared with the control plasmid (CAG-Td) (Fig. 6g).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn isolated myofibers, p21 and Wnt4 were significantly upregulated and downregulated, respectively, in Cre+ myofibers compared to Cre− myofibers.
“The expression of p21 and Wnt4 were significantly upregulated and downregulated, respectively, in Cre+ myofibers compared to Cre− myofibers (Fig. 6e).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn TA muscles of Acta1-Cre/4Fhet mice, p21 expression was upregulated and Wnt4 expression was downregulated in Cre+ muscles following Dox treatment, and returned to control levels following Dox withdrawal.
“Levels of p21 and Wnt4 expression were upregulated and downregulated in Cre+ muscles, respectively, following Dox treatment, and returned to control levels (i.e., levels seen in Cre− samples) following Dox withdrawal (Fig. 6c).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataBoth myofiber-specific and systemic OSKM induction increased the activation of SCs.
“Both myofiber-specific and systemic OSKM induction increased the activation of SCs.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationPartial reprogramming by short-term expression of reprogramming factors ameliorated aging hallmarks without tumor formation.
“Our lab showed that partial reprogramming by short-term expression of reprogramming factors ameliorated aging hallmarks without tumor formation8, opening a possible application of this approach in vivo.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [8] Ocampo, A. et al. In vivo amelioration of age-associated hallmarks by partial reprogramming. Cell 167, e1712 (2016). 1719-1733. source
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationThe regenerative capacity of SCs is influenced by both intrinsic modulators and the extrinsic microenvironment.
“The regenerative capacity of SCs is influenced by both intrinsic modulators and the extrinsic microenvironment13–15.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [13] Blau, H. M., Cosgrove, B. D. & Ho, A. T. The central role of muscle stem cells in regenerative failure with aging. Nat. Med. 21, 854–862 (2015). source
Not checked in the free run.
- cites [14] Sousa-Victor, P. et al. Geriatric muscle stem cells switch reversible quiescence into senescence. Nature 506, 316–321 (2014). source
Not checked in the free run.
- cites [15] Brack, A. S. & Munoz-Canoves, P. The ins and outs of muscle stem cell aging. Skelet. Muscle 6, 1 (2016). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Interpretationown dataFast-twitch muscles are a more appropriate model for evaluating the effects of OSKM on muscle regenerative capacity.
“These results suggest that fast-twitch muscles are a more appropriate model for evaluating the effects of OSKM on muscle regenerative capacity.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
PremisecitationMuscle regeneration is primarily mediated by muscle stem cells or satellite cells (SCs), which reside in a characteristic niche located between the basal lamina and plasma membrane of myofibers.
“Muscle regeneration is primarily mediated by muscle stem cells or satellite cells (SCs), which reside in a characteristic niche located between the basal lamina and plasma membrane of myofibers12.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [12] Mauro, A. Satellite cell of skeletal muscle fibers. J. Biophys. Biochem. Cytol. 9, 493 (1961). source
Not checked in the free run.
May combine two claims.
Interpretationown dataPartial reprogramming via OSKM can remodel the SC niche to induce SC activation and proliferation and accelerate muscle regeneration.
“We conclude that partial reprogramming via OSKM can remodel the SC niche to induce SC activation and proliferation and accelerate muscle regeneration.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataCre+ samples had an expansion of myoblasts without changing the SC number.
“In contrast, the number of Pax7+MyoD− SCs was comparable in Cre− and Cre+ samples (Fig. 2i), indicating Cre+ samples had an expansion of myoblasts without changing the SCs number.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataPartial reprogramming of myofibers induced the activation and proliferation of SCs.
“Together, these results suggest that partial reprogramming of myofibers induced the activation and proliferation of SCs.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataPartial reprogramming of myofibers induced the activation and proliferation of SCs and the expansion of myoblasts.
“Collectively, these results prove that partial reprogramming of myofibers induced the activation and proliferation of SCs and the expansion of myoblasts.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationOct4 represses the expression of MyoD.
“OSKM inhibited the expression of MyoD and miR-133a (Supplementary Fig. 7b), which is consistent with the finding that Oct4 represses the expression of MyoD18.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [18] Watanabe, S. et al. MyoD gene suppression by Oct4 is required for reprogramming in myoblasts to produce induced pluripotent stem cells. Stem Cells 29, 505–516 (2011). source
Not checked in the free run.
May combine two claims.
Interpretationown dataMyofiber-specific OSKM induction promotes SC activation and proliferation and accelerates muscle regeneration independent of aging.
“Together, these results indicate that myofiber-specific OSKM induction promotes SC activation and proliferation and accelerates muscle regeneration independent of aging.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
PremisecitationIn mouse keratinocytes, p21 inhibits Wnt4 expression by binding to the TATA-proximal region of the Wnt4 promoter in association with E2F-1.
“In mouse keratinocytes, p21 inhibits Wnt4 expression by binding to the TATA-proximal region of the Wnt4 promoter in association with E2F transcription factor 1 (E2F-1)24, and levels of p21 expression were negatively correlated with Wnt4 expression in our RNA-seq analysis (Fig. 6b).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [24] Devgan, V., Mammucari, C., Millar, S. E., Brisken, C. & Dotto, G. P. p21WAF1/Cip1 is a negative transcriptional regulator of Wnt4 expression downstream of Notch1 activation. Genes Dev. 19, 1485–1495 (2005). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationItga7 is a laminin-binding protein that connects myofibers to the basal lamina to maintain sarcolemma integrity.
“Integrin subunit alpha 7 (Itga7) is a laminin-binding protein that connects myofibers to the basal lamina to maintain sarcolemma integrity20.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [20] Mayer, U. et al. Absence of integrin alpha 7 causes a novel form of muscular dystrophy. Nat. Genet. 17, 318–323 (1997). source
Not checked in the free run.
May combine two claims.
PremisecitationLoss of Wnt4 in myofibers induces the activation of SCs and accelerates muscle regeneration.
“Loss of Wnt4 in myofibers induces the activation of SCs and accelerates muscle regeneration23.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [23] Eliazer, S. et al. Wnt4 from the niche controls the mechano-properties and quiescent state of muscle stem cells. Cell Stem Cell 25, 654–665.e4 (2019). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationSdc4 is expressed in SCs and is required for SC activation.
“Syndecan-4 (Sdc4) is expressed in SCs and is required for SC activation21,22, but a role for Sdc4 in myofibers remains elusive.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [21] Bentzinger, C. F. et al. Fibronectin regulates Wnt7a signaling and satellite cell expansion. Cell Stem Cell 12, 75–87 (2013). source
Not checked in the free run.
- cites [22] Cornelison, D. D. et al. Essential and separable roles for Syndecan-3 and Syndecan-4 in skeletal muscle development and regeneration. Genes Dev. 18, 2231–2236 (2004). source
Not checked in the free run.
May combine two claims.
PremisecitationDeletion of collagen VI or laminin-α1 (ECM components) or myofiber-specific deletion of O-fucosyltransferase 1 gene (Pofut1) impairs the self-renewal of SCs, leading to the shrinkage of the SC pool after multiple muscle injuries.
“Deletion of collagen VI or laminin-α1 (ECM components) or myofiber-specific deletion of O-fucosyltransferase 1 gene (Pofut1) impairs the self-renewal of SCs36–38, leading to the shrinkage of the SC pool after multiple muscle injuries.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [36] Rayagiri, S. S. et al. Basal lamina remodeling at the skeletal muscle stem cell niche mediates stem cell self-renewal. Nat. Commun. 9, 1075 (2018). source
Not checked in the free run.
- cites [37] Urciuolo, A. et al. Collagen VI regulates satellite cell self-renewal and muscle regeneration. Nat. Commun. 4, 1964 (2013). source
Not checked in the free run.
- cites [38] Zygmunt D. A. et al. Deletion of Pofut1 in mouse skeletal Myofibers induces muscle aging-related phenotypes in cis and in trans. Mol. Cell. Biol. 37, e00426–16 (2017). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationReprogramming factors have been shown to promote axon regeneration through intrinsic rejuvenation of retinal ganglion cells.
“Reprogramming factors have been shown to promote axon regeneration through intrinsic rejuvenation of retinal ganglion cells10.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [10] Lu, Y. et al. Reprogramming to recover youthful epigenetic information and restore vision. Nature 588, 124–129 (2020). source
Not checked in the free run.
May combine two claims.
InterpretationreasoningOur results suggest an aging-independent effect of reprogramming factors on muscle regeneration through remodeling of the extrinsic niche but not by regulating the intrinsic modulators of SCs.
“In contrast, our results suggest an aging-independent effect of reprogramming factors on muscle regeneration through remodeling of the extrinsic niche but not by regulating the intrinsic modulators of SCs.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningThe increase in activated SCs accelerated muscle regeneration, which may partly explain the previous observation that muscle regeneration was promoted in aging systemic 4F mice.
“The increase in activated SCs accelerated muscle regeneration, which may partly explain our previous observation that muscle regeneration was promoted in aging systemic 4F mice8.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [8] Ocampo, A. et al. In vivo amelioration of age-associated hallmarks by partial reprogramming. Cell 167, e1712 (2016). 1719-1733. source
Not checked in the free run.
- Rests on an assumption: SC activation is required for muscle regeneration.
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningLonger time may be required to observe the effect of OSKM on SC number in naturally aging mice.
“The aging process is much slower in WT mice compared to progeria mice and longer time may be required to observe the effect of OSKM on SC number in naturally aging mice.”
Quote in the paperNot a substantial claim- Rests on an assumption: The aging process is much slower in WT mice compared to progeria mice.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIntrinsic modulators control SC-initiated postnatal myogenesis.
“Intrinsic modulators control SC-initiated postnatal myogenesis29.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [29] Dumont, N. A., Wang, Y. X. & Rudnicki, M. A. Intrinsic and extrinsic mechanisms regulating satellite cell function. Development 142, 1572–1581 (2015). source
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationSelf-renewal of SCs is maintained by the SC niche, including, but not limited to ECM components and myofibers.
“Self-renewal of SCs is maintained by the SC niche, including, but not limited to ECM components and myofibers34,35.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [34] Kuang, S., Gillespie, M. A. & Rudnicki, M. A. Niche regulation of muscle satellite cell self-renewal and differentiation. Cell Stem Cell 2, 22–31 (2008). source
Not checked in the free run.
- cites [35] Yin, H., Price, F. & Rudnicki, M. A. Satellite cells and the muscle stem cell niche. Physiol. Rev. 93, 23–67 (2013). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationOSKM induction triggers complex cellular changes.
“OSKM induction triggers complex cellular changes1–3.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [1] Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861–872 (2007). source
Not checked in the free run.
- cites [2] Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663–676 (2006). source
Not checked in the free run.
- cites [3] Polo, J. M. et al. A molecular roadmap of reprogramming somatic cells into iPS cells. Cell 151, 1617–1632 (2012). source
Not checked in the free run.
Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing). May combine two claims.
InterpretationreasoningThe identification of effective downstream targets of OSKM would restrict unwanted outcomes and benefit the development of new approaches to facilitate tissue regeneration.
“The identification of their effective downstream targets would restrict unwanted outcomes and benefit the development of new approaches to facilitate tissue regeneration.”
Quote in the paperNot a substantial claim
The paper relies on this without support.
Young mice lack aging-related decline, so any OSKM-induced improvement in muscle regeneration in them cannot be attributed to rejuvenation of aged cells.
“In addition, we chose young mice to investigate whether the improvement of regeneration can be achieved by OSKM induction regardless of its rejuvenating effect.”
The paper relies on this without support.
The aging process is much slower in WT mice compared to progeria mice.
“The aging process is much slower in WT mice compared to progeria mice and longer time may be required to observe the effect of OSKM on SC number in naturally aging mice.”
The paper relies on this without support.
The intrinsic regulatory machinery is efficient in young SCs.
“The intrinsic regulatory machinery is efficient in young SCs, therefore, further improvement of SC quality is limited.”
The paper relies on this without support.
SC activation is required for muscle regeneration.
“SCs activation is required for muscle regeneration, but the activation kinetics is delayed in aged SCs30.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Expression of OSKM in myofibres, but not in MuSCs, promotes regeneration of old muscles.
“The beneficial effects of OSKM on muscle function may be not cell autonomous: indeed expression of OSKM in myofibres, but not in MuSCs, promotes regeneration of old muscles232.”
From Ageing and rejuvenation of tissue stem cells and their niches (2023) · cites this paper as [232]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Fig. 2i is cited for the wrong experimental groups
MinorThe Wnt4-knockdown section cites Fig. 2i as evidence for a comparison between control and knockdown muscles. Earlier, the paper describes Fig. 2i as comparing Cre− and Cre+ muscles in the OSKM-induction experiment, not the Wnt4-knockdown groups.
“In contrast, the number of Pax7+MyoD− SCs was comparable in control and KD samples (Fig. 2i), indicating Cre+ samples had an expansion of myoblasts without changing the SCs number.”
“In contrast, the number of Pax7+MyoD− SCs was comparable in Cre− and Cre+ samples (Fig. 2i), indicating Cre+ samples had an expansion of myoblasts without changing the SCs number.”
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106 · see citing works
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709 · see citing works
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673 · see citing works
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221 · see citing works
Heinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y. C., Laslo, P., Cheng, J. X., Murre, C., Singh, H., & Glass, C. K. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.004 · Cited by 13,382 · see citing works
SATELLITE CELL OF SKELETAL MUSCLE FIBERS
Mauro, A. (1961) · The Journal of Cell Biology · doi:10.1083/jcb.9.2.493 · Cited by 3,683 · see citing works
The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation
Chen, J., Mandel, E. M., Thomson, J. M., Wu, Q., Callis, T. E., Hammond, S. M., Conlon, F. L., & Wang, D.-Z. (2005) · Nature Genetics · doi:10.1038/ng1725 · Cited by 2,763 · see citing works
Satellite Cells and the Muscle Stem Cell Niche
Yin, H., Price, F., & Rudnicki, M. A. (2013) · Physiological Reviews · doi:10.1152/physrev.00043.2011 · Cited by 2,166 · see citing works
CHOPCHOP v3: expanding the CRISPR web toolbox beyond genome editing
Labun, K., Montague, T. G., Krause, M., Cleuren, Y. N. T., Tjeldnes, H., & Valen, E. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz365 · Cited by 2,009 · see citing works
Suppression of induced pluripotent stem cell generation by the p53–p21 pathway
Hong, H., Takahashi, K., Ichisaka, T., Aoi, T., Kanagawa, O., Nakagawa, M., Okita, K., & Yamanaka, S. (2009) · Nature · doi:10.1038/nature08235 · Cited by 1,301 · see citing works
Murphy, M. M., Lawson, J. A., Mathew, S. J., Hutcheson, D. A., & Kardon, G. (2011) · Development · doi:10.1242/dev.064162 · Cited by 1,249 · see citing works
Transcriptome Engineering with RNA-Targeting Type VI-D CRISPR Effectors
Konermann, S., Lotfy, P., Brideau, N. J., Oki, J., Shokhirev, M. N., & Hsu, P. D. (2018) · Cell · doi:10.1016/j.cell.2018.02.033 · Cited by 1,164 · see citing works
Geriatric muscle stem cells switch reversible quiescence into senescence
Sousa-Victor, P., Gutarra, S., García-Prat, L., Rodriguez-Ubreva, J., Ortet, L., Ruiz-Bonilla, V., Jardí, M., Ballestar, E., González, S., Serrano, A. L., et al. (2014) · Nature · doi:10.1038/nature13013 · Cited by 1,010 · see citing works
In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming.
Ocampo, A., Reddy, P., Martinez-Redondo, P., Platero-Luengo, A., Hatanaka, F., Hishida, T., Li, M., Lam, D., Kurita, M., Beyret, E., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.052 · Cited by 988 · see citing works
Self-citationGene transfer into muscle by electroporation in vivo
Aihara, H., & Miyazaki, J. (1998) · Nature Biotechnology · doi:10.1038/nbt0998-867 · Cited by 945 · see citing works
A Molecular Roadmap of Reprogramming Somatic Cells into iPS Cells
Polo, J. M., Anderssen, E., Walsh, R. M., Schwarz, B. A., Nefzger, C. M., Lim, S. M., Borkent, M., Apostolou, E., Alaei, S., Cloutier, J., et al. (2012) · Cell · doi:10.1016/j.cell.2012.11.039 · Cited by 861 · see citing works
Hochedlinger, K., Yamada, Y., Beard, C., & Jaenisch, R. (2005) · Cell · doi:10.1016/j.cell.2005.02.018 · Cited by 841 · see citing works
Reprogramming to recover youthful epigenetic information and restore vision
Lu, Y., Brommer, B., Tian, X., Krishnan, A., Meer, M., Wang, C., Vera, D. L., Zeng, Q., Yu, D., Bonkowski, M. S., et al. (2020) · Nature · doi:10.1038/s41586-020-2975-4 · Cited by 820 · see citing works
Self-citationMyostatin negatively regulates satellite cell activation and self-renewal
McCroskery, S., Thomas, M., Maxwell, L., Sharma, M., & Kambadur, R. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200207056 · Cited by 784 · see citing works
Reprogramming in vivo produces teratomas and iPS cells with totipotency features
Abad, M., Mosteiro, L., Pantoja, C., Cañamero, M., Rayon, T., Ors, I., Graña, O., Megías, D., Domínguez, O., Martínez, D., et al. (2013) · Nature · doi:10.1038/nature12586 · Cited by 547 · see citing works
Collagen VI regulates satellite cell self-renewal and muscle regeneration
Urciuolo, A., Quarta, M., Morbidoni, V., Gattazzo, F., Molon, S., Grumati, P., Montemurro, F., Tedesco, F. S., Blaauw, B., Cossu, G., et al. (2013) · Nature Communications · doi:10.1038/ncomms2964 · Cited by 511 · see citing works
Niche Regulation of Muscle Satellite Cell Self-Renewal and Differentiation
Kuang, S., Gillespie, M. A., & Rudnicki, M. A. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2007.12.012 · Cited by 507 · see citing works
Intrinsic and extrinsic mechanisms regulating satellite cell function
Dumont, N. A., Wang, Y. X., & Rudnicki, M. A. (2015) · Development · doi:10.1242/dev.114223 · Cited by 491 · see citing works
[Cellular receptors for animal viruses].
HOMMA, R., & Yasui, K. (1968) · PubMed · Cited by 485 · see citing works
Ohnishi, K., Semi, K., Yamamoto, T., Shimizu, M., Tanaka, A., Mitsunaga, K., Okita, K., Osafune, K., Arioka, Y., Maeda, T., et al. (2014) · Cell · doi:10.1016/j.cell.2014.01.005 · Cited by 460 · see citing works
Absence of integrin α7 causes a novel form of muscular dystrophy
Mayer, U., Saher, G., Fässler, R., Bornemann, A., Echtermeyer, F., Mark, H. V. D., Miosge, N., Pösch, E., & Mark, K. V. D. (1997) · Nature Genetics · doi:10.1038/ng1197-318 · Cited by 451 · see citing works
In vivo target gene activation via CRISPR/Cas9-mediated trans-epigenetic modulation
Liao, H.-K., Hatanaka, F., Araoka, T., Reddy, P., Wu, M.-Z., Sui, Y., Yamauchi, T., Sakurai, M., O’Keefe, D. D., Núñez-Delicado, E., et al. (2017) · Cell · doi:10.1016/j.cell.2017.10.025 · Cited by 451 · see citing works
Self-citationThe central role of muscle stem cells in regenerative failure with aging
Blau, H. M., Cosgrove, B. D., & Ho, A. T. V. (2015) · Nature Medicine · doi:10.1038/nm.3918 · Cited by 437 · see citing works
Belteki, G., Haigh, J., Kabacs, N., Haigh, K., Sison, K., Costantini, F., Whitsett, J., Quaggin, S., & Nagy, A. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni051 · Cited by 423 · see citing works
Fibronectin Regulates Wnt7a Signaling and Satellite Cell Expansion
Bentzinger, C. F., Wang, Y. X., von Maltzahn, J., Soleimani, V. D., Yin, H., & Rudnicki, M. A. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2012.09.015 · Cited by 386 · see citing works
Fry, C. S., Kirby, T. J., Kosmac, K., McCarthy, J. J., & Peterson, C. A. (2017) · Cell stem cell · doi:10.1016/j.stem.2016.09.010 · Cited by 372 · see citing works
Verma, M., Asakura, Y., Murakonda, B. S. R., Pengo, T., Latroche, C., Chazaud, B., McLoon, L. K., & Asakura, A. (2018) · Cell stem cell · doi:10.1016/j.stem.2018.09.007 · Cited by 349 · see citing works
Cornelison, D. D. W., Wilcox-Adelman, S. A., Goetinck, P. F., Rauvala, H., Rapraeger, A. C., & Olwin, B. B. (2004) · Genes & Development · doi:10.1101/gad.1214204 · Cited by 317 · see citing works
Sarkar, T. J., Quarta, M., Mukherjee, S., Colville, A., Paine, P., Doan, L., Tran, C. M., Chu, C. R., Horvath, S., Qi, L. S., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15174-3 · Cited by 308 · see citing works
A reprogrammable mouse strain from gene targeted embryonic stem cells
Stadtfeld, M., Maherali, N., Borkent, M., & Hochedlinger, K. (2009) · Nature Methods · doi:10.1038/nmeth.1409 · Cited by 254 · see citing works
Gene targeting restricted to mouse striated muscle lineage
Miniou, P. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.19.e27 · Cited by 226 · see citing works
Basal lamina remodeling at the skeletal muscle stem cell niche mediates stem cell self-renewal
Rayagiri, S. S., Ranaldi, D., Raven, A., Mohamad Azhar, N. I. F., Lefebvre, O., Zammit, P. S., & Borycki, A.-G. (2018) · Nature Communications · doi:10.1038/s41467-018-03425-3 · Cited by 218 · see citing works
Devgan, V., Mammucari, C., Millar, S. E., Brisken, C., & Dotto, G. P. (2005) · Genes & Development · doi:10.1101/gad.341405 · Cited by 209 · see citing works
Wnt4 from the Niche Controls the Mechano-Properties and Quiescent State of Muscle Stem Cells
Eliazer, S., Muncie, J. M., Christensen, J., Sun, X., D’Urso, R. S., Weaver, V. M., & Brack, A. S. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2019.08.007 · Cited by 171 · see citing works
The ins and outs of muscle stem cell aging
Brack, A. S., & Muñoz-Cánoves, P. (2015) · Skeletal Muscle · doi:10.1186/s13395-016-0072-z · Cited by 166 · see citing works
Niche Cadherins Control the Quiescence-to-Activation Transition in Muscle Stem Cells
Goel, A. J., Rieder, M.-K., Arnold, H.-H., Radice, G. L., & Krauss, R. S. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.10.102 · Cited by 146 · see citing works
Gene Transfer into Muscle by Electroporation In Vivo
Miyazaki, J., & Aihara, H. (2003) · Humana Press eBooks · doi:10.1385/1-59259-141-8:049 · Cited by 140 · see citing works
REPROGRAMMED CELLS FOR DISEASE MODELING AND REGENERATIVE MEDICINE
Cherry, A. B. C., & Daley, G. (2013) · Annual Review of Medicine · doi:10.1146/annurev-med-050311-163324 · Cited by 137 · see citing works
Wang, C., Yue, F., & Kuang, S. (2017) · BIO-PROTOCOL · doi:10.21769/bioprotoc.2279 · Cited by 134 · see citing works
Self-citationMacrophage-released ADAMTS1 promotes muscle stem cell activation
Du, H., Shih, C., Wosczyna, M. N., Mueller, A. A., Cho, J., Aggarwal, A., Rando, T. A., & Feldman, B. J. (2017) · Nature Communications · doi:10.1038/s41467-017-00522-7 · Cited by 128 · see citing works
Pten is necessary for the quiescence and maintenance of adult muscle stem cells
Yue, F., Bi, P., Wang, C., Shan, T., Nie, Y., Ratliff, T. L., Gavin, T. P., & Kuang, S. (2017) · Nature Communications · doi:10.1038/ncomms14328 · Cited by 120 · see citing works
Self-citationIn Vivo Reprogramming Ameliorates Aging Features in Dentate Gyrus Cells and Improves Memory in Mice.
Rodríguez-Matellán, A., Alcazar, N., Hernández, F., Serrano, M., & Ávila, J. (2020) · Stem Cell Reports · doi:10.1016/j.stemcr.2020.09.010 · Cited by 116 · see citing works
Aging induces aberrant state transition kinetics in murine muscle stem cells
Kimmel, J. C., Hwang, A. B., Scaramozza, A., Marshall, W. F., & Brack, A. S. (2020) · Development · doi:10.1242/dev.183855 · Cited by 95 · see citing works
Nie, Y., Sato, Y., Wang, C., Yue, F., Kuang, S., & Gavin, T. P. (2016) · The FASEB Journal · doi:10.1096/fj.201600529r · Cited by 90 · see citing works
Self-citationLoss of MyoD Promotes Fate Transdifferentiation of Myoblasts Into Brown Adipocytes
Wang, C., Liu, W., Nie, Y., Qaher, M., Horton, H. E., Yue, F., Asakura, A., & Kuang, S. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.01.015 · Cited by 76 · see citing works
Self-citationIn vivo reprogramming drives Kras-induced cancer development
Shibata, H., Komura, S., Yamada, Y., Sankoda, N., Tanaka, A., Ukai, T., Kabata, M., Sakurai, S., Kuze, B., Woltjen, K., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04449-5 · Cited by 76 · see citing works
Okamoto, T., Kurahashi, K., & Fujiwara, M. (1988) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24089-7 · Cited by 56 · see citing works
Pisconti, A., Banks, G. B., Babaeijandaghi, F., Betta, N. D., Rossi, F. M. V., Chamberlain, J. S., & Olwin, B. B. (2016) · Skeletal Muscle · doi:10.1186/s13395-016-0104-8 · Cited by 50 · see citing works
Watanabe, S., Hirai, H., Asakura, Y., Tastad, C., Verma, M., Keller, C., Dutton, J. R., & Asakura, A. (2011) · Stem Cells · doi:10.1002/stem.598 · Cited by 44 · see citing works
Zygmunt, D. A., Singhal, N., Kim, M.-L., Cramer, M. L., Crowe, K. E., Xu, R., Jia, Y., Adair, J., Martinez-Pena y Valenzuela, I., Akaaboune, M., et al. (2017) · Molecular and Cellular Biology · doi:10.1128/mcb.00426-16 · Cited by 15 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Meta-hallmarks of aging and cancer
López-Otín, C., Pietrocola, F., Roiz-Valle, D., Galluzzi, L., & Kroemer, G. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2022.11.001 · Cited by 529 · see citing works
Control of satellite cell function in muscle regeneration and its disruption in ageing
Sousa-Victor, P., García-Prat, L., & Muñoz-Cánoves, P. (2022) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00421-2 · Cited by 476 · see citing works
Ageing and rejuvenation of tissue stem cells and their niches
Brunet, A., Goodell, M. A., & Rando, T. A. (2023) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-022-00510-w · Cited by 407 · see citing works
Browder, K. C., Reddy, P., Yamamoto, M., Haghani, A., Guillen, I. G., Sahu, S., Wang, C., Luque, Y., Prieto, J., Shi, L., et al. (2022) · Nature Aging · doi:10.1038/s43587-022-00183-2 · Cited by 253 · see citing works
Self-citationHuman organoids-on-chips for biomedical research and applications
Wang, H., Ning, X., Zhao, F. H., Zhao, H., & Li, D. (2024) · Theranostics · doi:10.7150/thno.90492 · Cited by 138 · see citing works
The emergence of the stem cell niche
Hicks, M. R., & Pyle, A. D. (2022) · Trends in Cell Biology · doi:10.1016/j.tcb.2022.07.003 · Cited by 112 · see citing works
In vivo partial cellular reprogramming enhances liver plasticity and regeneration
Hishida, T., Yamamoto, M., Hishida, Y., Shao, C., Huang, L., Wang, C., Shojima, K., Xue, Y., Hang, Y., Shokhirev, M. N., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110730 · Cited by 111 · see citing works
Self-citationLarge-scale chromatin reorganization reactivates placenta-specific genes that drive cellular aging
Liu, Z., Ji, Q., Ren, J., Yan, P., Wu, Z., Wang, S., Sun, L., Wang, Z., Li, J., Sun, G., et al. (2022) · Developmental Cell · doi:10.1016/j.devcel.2022.05.004 · Cited by 109 · see citing works
Poss, K. D., & Tanaka, E. M. (2024) · Cell stem cell · doi:10.1016/j.stem.2024.07.007 · Cited by 94 · see citing works
Skeletal muscle: molecular structure, myogenesis, biological functions, and diseases
Feng, L., Chen, Z., & Bian, H. (2024) · MedComm · doi:10.1002/mco2.649 · Cited by 95 · see citing works
Roux, A. E., Zhang, C., Paw, J. S., Zavala‐Solorio, J., Malahias, E., Vijay, T., Kolumam, G. A., Kenyon, C. J., & Kimmel, J. C. (2022) · Cell Systems · doi:10.1016/j.cels.2022.05.002 · Cited by 83 · see citing works
Alle, Q., Borgne, E. L., Bensadoun, P., Lemey, C., Béchir, N., Gabanou, M., Estermann, F. E., Bertrand‐Gaday, C., Pessemesse, L., Toupet, K., et al. (2022) · Aging Cell · doi:10.1111/acel.13714 · Cited by 75 · see citing works
Jing, Y., Jiang, X., Ji, Q., Wu, Z., Wang, W., Liu, Z., Guillén-García, P., Esteban, C. R., Reddy, P., Horvath, S., et al. (2023) · Cell stem cell · doi:10.1016/j.stem.2023.09.007 · Cited by 76 · see citing works
Self-citationThe long and winding road of reprogramming-induced rejuvenation
Yücel, A. D., & Gladyshev, V. N. (2024) · Nature Communications · doi:10.1038/s41467-024-46020-5 · Cited by 76 · see citing works
Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming
Cipriano, A., Moqri, M., Maybury‐Lewis, S. Y., Rogers-Hammond, R., de Jong, T. A., Parker, A., Rasouli, S., Schöler, H. R., Sinclair, D. A., & Sebastiano, V. (2023) · Nature Aging · doi:10.1038/s43587-023-00539-2 · Cited by 65 · see citing works
Rando, T. A., Brunet, A., & Goodell, M. A. (2025) · Cell stem cell · doi:10.1016/j.stem.2025.06.004 · Cited by 66 · see citing works
In vivo reprogramming leads to premature death linked to hepatic and intestinal failure
Parras, A., Vílchez-Acosta, A., Desdín-Micó, G., Picó, S., Mrabti, C., Montenegro-Borbolla, E., Maroun, C. Y., Haghani, A., Brooke, R. T., Maza, M. D. C. L., et al. (2023) · Nature Aging · doi:10.1038/s43587-023-00528-5 · Cited by 57 · see citing works
Velikic, G. S., Maric, D. M., Marić, D., Šupić, G., Puletić, M., Dulić, O., & Vojvodić, D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020993 · Cited by 57 · see citing works
Cellular plasticity in reprogramming, rejuvenation and tumorigenesis: a pioneer TF perspective
Huyghe, A., Trajkova, A., & Lavial, F. (2023) · Trends in Cell Biology · doi:10.1016/j.tcb.2023.07.013 · Cited by 55 · see citing works
Aguirre, M., Escobar, M., Amézquita, S. F., Cubillos, D., Romero, C. A. R., Vanegas, P., Tarazona, M. P., Escobar, S., Blanco, J. C., & Celis, L. G. (2023) · Genes · doi:10.3390/genes14091697 · Cited by 54 · see citing works
Jones, R. G., Dimet‐Wiley, A., Haghani, A., da Silva, F. M., Brightwell, C. R., Lim, S., Khadgi, S., Wen, Y., Dungan, C. M., Brooke, R. T., et al. (2022) · The Journal of Physiology · doi:10.1113/jp283836 · Cited by 47 · see citing works
Diverse Roles of Cellular Senescence in Skeletal Muscle Inflammation, Regeneration, and Therapeutics
Saito, Y., & Chikenji, T. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.739510 · Cited by 48 · see citing works
Age reprogramming: cell rejuvenation by partial reprogramming
Singh, P. B., & Zhakupova, A. (2022) · Development · doi:10.1242/dev.200755 · Cited by 47 · see citing works
Refeeding-associated AMPKγ1 complex activity is a hallmark of health and longevity
Ripa, R., Ballhysa, E., Steiner, J. D., Laboy, R., Annibal, A., Hochhard, N., Latza, C., Dolfi, L., Calabrese, C., Meyer, A. M., et al. (2023) · Nature Aging · doi:10.1038/s43587-023-00521-y · Cited by 43 · see citing works
Restoration of neuronal progenitors by partial reprogramming in the aged neurogenic niche
Xu, L., Ramirez-Matias, J., Hauptschein, M., Sun, E., Lunger, J. C., Buckley, M. T., & Brunet, A. (2024) · Nature Aging · doi:10.1038/s43587-024-00594-3 · Cited by 40 · see citing works
Kim, J., Kim, S., Lee, S., Jo, B., Oh, J. Y., Kwon, E., Kim, K.-T., Adpaikar, A. A., Kim, E., Jung, H.-S., et al. (2023) · Science Advances · doi:10.1126/sciadv.adi8454 · Cited by 37 · see citing works
Context‐dependent roles of cellular senescence in normal, aged, and disease states
Moiseeva, V., Cisneros, A., Cobos, A. C., Tarrega, A. B., Oñate, C. S., Perdiguero, E., Serrano, A. L., & Muñoz‐Cánoves, P. (2023) · The FEBS Journal · doi:10.1111/febs.16573 · Cited by 34 · see citing works
Partial cellular reprogramming: A deep dive into an emerging rejuvenation technology
Paine, P., Nguyen, A. T., & Ocampo, A. (2023) · Aging Cell · doi:10.1111/acel.14039 · Cited by 38 · see citing works
Antón‐Fernández, A., Roldán-Lázaro, M., Vallés‐Saiz, L., Ávila, J., & Hernández, F. (2024) · Communications Biology · doi:10.1038/s42003-024-06328-w · Cited by 28 · see citing works
Rejuvenation of Tissue Stem Cells by Intrinsic and Extrinsic Factors
Cai, Y., Wang, S., Qu, J. T., Belmonte, J. C. I., & Liu, G. (2021) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szab012 · Cited by 26 · see citing works
Kim, J., Hwang, Y., Kim, S., Chang, Y., Kim, Y.-K., Kwon, Y., & Kim, J. (2023) · Aging Cell · doi:10.1111/acel.13825 · Cited by 24 · see citing works
Expansion of the neocortex and protection from neurodegeneration by in vivo transient reprogramming
Shen, Y.-R., Zaballa, S., Bech, X., Sancho‐Balsells, A., Rodríguez-Navarro, I., Cifuentes-Díaz, C., Seyit-Bremer, G., Chun, S. H., Straub, T., Abante, J., et al. (2024) · Cell stem cell · doi:10.1016/j.stem.2024.09.013 · Cited by 26 · see citing works
Targeting immunosenescence for improved tumor immunotherapy
Liu, Z., Zuo, L., Zhou, Z., Liu, S., Ba, Y., Zuo, A., Ren, Y., Zhang, C., Chen, Y., Ma, H., et al. (2024) · MedComm · doi:10.1002/mco2.777 · Cited by 24 · see citing works
Decline of regenerative potential of old muscle stem cells: contribution to muscle aging
Sahinyan, K., Lazure, F., Blackburn, D. M., & Soleimani, V. D. (2022) · FEBS Journal · doi:10.1111/febs.16352 · Cited by 25 · see citing works
Li, N., Chen, Y., Wang, Q., Liu, X., Han, C., Qu, C., Guan, X., Zou, W., Wang, X., Li, A., et al. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04481-5 · Cited by 24 · see citing works
Hepatocyte reprogramming in liver regeneration: Biological mechanisms and applications
Jiang, M., Ren, J., Belmonte, J. C. I., & Liu, G. (2023) · FEBS Journal · doi:10.1111/febs.16930 · Cited by 20 · see citing works
Division-Independent Differentiation of Muscle Stem Cells During a Growth Stimulus
Ismaeel, A., Goh, J. Z., Mobley, C. B., Murach, K. A., Brett, J. O., de Morrée, A., Rando, T. A., Peterson, C. A., Wen, Y., & McCarthy, J. J. (2023) · Stem Cells · doi:10.1093/stmcls/sxad091 · Cited by 21 · see citing works
Cell-based regenerative and rejuvenation strategies for treating neurodegenerative diseases
Deng, S., Xie, H., & Xie, B. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04285-7 · Cited by 23 · see citing works
Stem cells as role models for reprogramming and repair
Götz, M., & Torres‐Padilla, M. (2025) · Science · doi:10.1126/science.adp2959 · Cited by 22 · see citing works
Novel strategies in nephrology: what to expect from the future?
Çöpür, S., Tanrıöver, C., Yavuz, F., Soler, M. J., Ortíz, A., Covic, A. C., & Kanbay, M. (2022) · Clinical Kidney Journal · doi:10.1093/ckj/sfac212 · Cited by 21 · see citing works
Rajabian, N., Choudhury, D., Ikhapoh, I. A., Saha, S., Kalyankar, A. S., Mehrotra, P., Shahini, A., Breed, K., & Andreadis, S. T. (2023) · Aging Cell · doi:10.1111/acel.13764 · Cited by 19 · see citing works
Margotta, C., Fabbrizio, P., Ceccanti, M., Cambieri, C., Ruffolo, G., D’Agostino, J., Trolese, M. C., Cifelli, P., Alfano, V., Laurini, C., et al. (2023) · Inflammation and Regeneration · doi:10.1186/s41232-023-00270-w · Cited by 17 · see citing works
ImAge quantitates aging and rejuvenation
Alvarez-Kuglen, M., Ninomiya, K., Qin, H., Rodriguez, D., Fiengo, L., Farhy, C., Hsu, W.-M., Kirk, B. D., Havas, A. P., Kaufman, C., et al. (2024) · Nature Aging · doi:10.1038/s43587-024-00685-1 · Cited by 17 · see citing works
Manipulating cell fate through reprogramming: approaches and applications.
Yagi, M., Horng, J. E., & Hochedlinger, K. (2024) · Development · doi:10.1242/dev.203090 · Cited by 15 · see citing works
Metabolic regulation in adult and aging skeletal muscle stem cellsPreprint
Sartorelli, V., & Ciuffoli, V. (2024) · Genes & Development · doi:10.1101/gad.352277.124 · Cited by 18 · see citing works
Hernández‐Benítez, R., Wang, C., Shi, L., Ouchi, Y., Zhong, C., Hishida, T., Liao, H., Magill, E. A., Memczak, S., Soligalla, R. D., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101449 · Cited by 16 · see citing works
Self-citationPhysical training reduces cell senescence and associated insulin resistance in skeletal muscle
Podraza-Farhanieh, A., Spinelli, R., Zatterale, F., Nerstedt, A., Gogg, S., Blüher, M., & Smith, U. (2025) · Molecular Metabolism · doi:10.1016/j.molmet.2025.102130 · Cited by 16 · see citing works
Exercise-Induced MYC as an Epigenetic Reprogramming Factor That Combats Skeletal Muscle Aging
Jones, R. G., von Walden, F., & Murach, K. A. (2024) · Exercise and Sport Sciences Reviews · doi:10.1249/jes.0000000000000333 · Cited by 15 · see citing works
Rejuvenating aged stem cells: therapeutic strategies to extend health and lifespan
Matteini, F., Montserrat‐Vazquez, S., & Florian, M. C. (2024) · FEBS Letters · doi:10.1002/1873-3468.14865 · Cited by 15 · see citing works
Infectious Keratitis: An Update on Role of Epigenetics
Verma, S., Singh, A., Varshney, A., Chandru, R. A., Acharya, M., Rajput, J., Sangwan, V., Tiwari, A. K., Bhowmick, T., & Tiwari, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.765890 · Cited by 15 · see citing works
Le, N., Awad, S., Palazzo, I., Hoang, T. V., & Blackshaw, S. (2025) · eLife · doi:10.7554/elife.106450 · Cited by 15 · see citing works
Sadria, M., & Layton, A. T. (2025) · Genome biology · doi:10.1186/s13059-025-03519-4 · Cited by 14 · see citing works
Muscle Stem Cell Microenvironment and Functions in Muscle Regeneration
Li, W., Chen, M., & Zhang, L. (2025) · Biomolecules · doi:10.3390/biom15060765 · Cited by 13 · see citing works
mRNA-based technology for engineered regenerative medicine
Zhen, X., Chen, W., & Tao, W. (2025) · Cell Biomaterials · doi:10.1016/j.celbio.2025.100185 · Cited by 14 · see citing works
Paine, P. T., Rechsteiner, C., Morandini, F., Desdín-Micó, G., Mrabti, C., Parras, A., Haghani, A., Brooke, R., Horvath, S., Seluanov, A., et al. (2024) · Frontiers in Aging · doi:10.3389/fragi.2023.1323194 · Cited by 13 · see citing works
Ha, J., Kim, B. S., Min, B., Nam, J., Lee, J.-G., Lee, M., Yoon, B.-H., Choi, Y. H., Im, I., Park, J. S., et al. (2022) · Science Advances · doi:10.1126/sciadv.abk1239 · Cited by 13 · see citing works
Hess, S., Kendall, T. J., Peña, M. T., Yamane, K., Soong, D. Y. H., Adams, L. B., Truman, R. W., & Rambukkana, A. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100820 · Cited by 13 · see citing works
Myc beyond Cancer: Regulation of Mammalian Tissue Regeneration
Illi, B., & Nasi, S. (2023) · Pathophysiology · doi:10.3390/pathophysiology30030027 · Cited by 12 · see citing works
Wang, P., Wang, R., Huo, Y., Peng, Y. H., Fu, C., Hu, Y., Ren, Z., Mulat, Y., Zhang, H., Jiang, D., et al. (2025) · Advanced Science · doi:10.1002/advs.202511019 · Cited by 13 · see citing works
Chemically induced revitalization of damaged hepatocytes for regenerative liver repair
Lin, P., Bai, Y., Nian, X.-X., Chi, J., Chen, T., Zhang, J., Zhang, W., Zhou, B., Liu, Y., & Zhao, Y. (2023) · iScience · doi:10.1016/j.isci.2023.108532 · Cited by 11 · see citing works
Comparisons between Plant and Animal Stem Cells Regarding Regeneration Potential and Application
Liu, L., Qiu, L., Zhu, Y., Luo, L., Han, X., Man, M., Li, F., Ren, M., & Xing, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054392 · Cited by 11 · see citing works
Lemaı̂tre, J.-M. (2024) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.19820 · Cited by 13 · see citing works
The occurrence and development of induced pluripotent stem cells
Chen, Y., Li, M., & Wu, Y. (2024) · Frontiers in Genetics · doi:10.3389/fgene.2024.1389558 · Cited by 14 · see citing works
Gene therapy strategies for aging intervention
Jing, Y., Ren, J., Qu, J. T., & Liu, G. (2025) · Cell Insight · doi:10.1016/j.cellin.2025.100254 · Cited by 10 · see citing works
Plasticity of muscle stem cells in homeostasis and aging
Porpiglia, E., & Blau, H. M. (2022) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2022.101999 · Cited by 9 · see citing works
Unlocking regeneration: how partial reprogramming resembles tissue healing
Adams, M. T., Jasper, H., & Mosteiro, L. (2025) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2025.102351 · Cited by 9 · see citing works
Unveiling the link: aging and its impact on ocular diseases
Wang, K., Xie, Y., Lin, Y., Zhu, R., Gao, T., Han, Z., Yang, Z., Jiang, X., Chen, H., Wu, Z., et al. (2025) · Experimental Eye Research · doi:10.1016/j.exer.2025.110551 · Cited by 11 · see citing works
In vivo Pooled Screening: A Scalable Tool to Study the Complexity of Aging and Age-Related Disease
Jensen, M. B., & Marblestone, A. H. (2021) · Frontiers in Aging · doi:10.3389/fragi.2021.714926 · Cited by 9 · see citing works
The origin, progress, and application of cell‐based cardiac regeneration therapy
Zhuo, D., Lei, I., Li, W., Liu, L., Li, L., Ni, J., Liu, Z., & Fan, G. (2023) · Journal of Cellular Physiology · doi:10.1002/jcp.31060 · Cited by 8 · see citing works
Organ‐Specific Dedifferentiation and Epigenetic Remodeling in In Vivo Reprogramming
Jo, B., Lee, S., Eom, H., Kim, J., & Cha, H. (2025) · Aging Cell · doi:10.1111/acel.70268 · Cited by 8 · see citing works
Lee, J., Han, M., Wang, K., Butler, L. R., & Sinclair, D. A. (2026) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2026.101442 · Cited by 7 · see citing works
Edman, S., Jones, R. G., Jannig, P. R., Fernandez‐Gonzalo, R., Norrbom, J., Thomas, N. T., Khadgi, S., Koopmans, P. J., da Silva, F. M., Peterson, C. S., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.26.586857 · Cited by 8 · see citing works
Li, Y.-Y., & Tay, F. R. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103009 · Cited by 7 · see citing works
Cellular senescence as a therapeutic target for aging intervention
Bi, Y., & Ji, G. (2026) · Biomedical Journal · doi:10.1016/j.bj.2026.100948 · Cited by 7 · see citing works
Overcoming muscle stem cell aging
Memczak, S., & Belmonte, J. C. I. (2023) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2023.102127 · Cited by 7 · see citing works
Partial Reprogramming as a Method for Regenerating Neural Tissues in Aged Organisms
Sichani, A. S., Khoddam, S., Shakeri, S., Tavakkoli, Z., Jafroodi, A. R., Dabbaghipour, R., Sisakht, M., & Fallahi, J. (2024) · Cellular Reprogramming · doi:10.1089/cell.2023.0123 · Cited by 7 · see citing works
Gao, H., Pathan, S., Dixon, B. R. E. A., Pugazenthi, A., Mathison, M. N., Mohamed, T., Rosengart, T. K., & Yang, J. (2024) · Scientific Reports · doi:10.1038/s41598-024-73975-8 · Cited by 7 · see citing works
Caron, L., Testa, S., & Magdinier, F. (2023) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-230076 · Cited by 7 · see citing works
Avelar, R. A., Palmer, D. H., Kulaga, A. Y., & Fuellen, G. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102737 · Cited by 8 · see citing works
Zhang, C., Bai, Y., Yin, Q., Li, J., Huang, K., & Qiu, M. R. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114569 · Cited by 6 · see citing works
Cellular Senescence in the Regenerative Niche Hampers Skeletal Muscle Repair
Qiu, M., Li, Y., Wang, Q., Jian, X., Huang, J.-W., Gui, W., Hu, J., & Liao, H. (2025) · Aging and Disease · doi:10.14336/ad.2024.1501 · Cited by 6 · see citing works
Self-citationJin, C., Ye, M., Song, Z., Zhang, Z., Gao, C., Yan, H., & Wang, X. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c01027 · Cited by 6 · see citing works
de Lázaro, I., Zhang, B., Makarova, N. E., Mariotti, M., Orejón-Sánchez, T. L., Tringides, C. M., Gladyshev, V. N., & Mooney, D. J. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.22.473302 · Cited by 6 · see citing works
Alam, Q., Ali, S., Ismail, P. M., & Hossain, A. S. (2026) · Energy & environment materials · doi:10.1002/eem2.70388 · Cited by 5 · see citing works
Inactivation of Tumor Suppressor CYLD Inhibits Fibroblast Reprogramming to Pluripotency
Bekas, N., Samiotaki, M. K., Papathanasiou, M., Mokos, P., Pseftogas, A., Xanthopoulos, K., Thanos, D., Mosialos, G., & Dafou, D. (2023) · Cancers · doi:10.3390/cancers15204997 · Cited by 4 · see citing works
Nakatsukasa, Y., Yamada, Y., & Yamada, Y. (2024) · Regenerative Therapy · doi:10.1016/j.reth.2024.11.008 · Cited by 7 · see citing works
Comparative analysis of mouse strains for in vivo induction of reprogramming factors
Picó, S., Vílchez-Acosta, A., de Sousa, J. A., Maza, M. D. C. L., Mrabti, C., Parras, A., Desdín-Micó, G., Maroun, C. Y., Branchina, C., von Meyenn, F., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115879 · Cited by 7 · see citing works
Stem Cell Aging and Rejuvenation in the Skeletal Muscle System
Libergoli, M., & Almada, A. E. (2025) · Rejuvenation Research · doi:10.1089/rej.2025.0028 · Cited by 4 · see citing works
Making sense of MYC in skeletal muscle: location, duration, and magnitude
Jones, R. G., Edman, S., Serrano, N., Wen, Y., McCarthy, J. J., Fry, C. S., von Walden, F., & Murach, K. A. (2025) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00528.2025 · Cited by 3 · see citing works
Cao, Q., Liu, J., Huang, G., Wang, S.-Y., Lu, G.-D., Huang, Y., Chen, Y.-T., Zhang, Z., Fu, J., Sun, S., et al. (2026) · Journal of Clinical Investigation · doi:10.1172/jci198076 · Cited by 6 · see citing works
A Youthful Touch: Reversal of Aging Hallmarks by Cell Reprogramming
Miliotou, E., & de Lázaro, I. (2024) · Cells Tissues Organs · doi:10.1159/000539415 · Cited by 4 · see citing works
Healthspan Extension through Innovative Genetic Medicines
Garcia, H., Brown, D. W., Scholz, M., & Lewis, J. D. (2021) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000009674 · Cited by 4 · see citing works
Convergence of aging- and rejuvenation-related epigenetic alterations on PRC2 targetsPreprint
Koldobskiy, M. A., Camacho, O. M., Reddy, P., Belmonte, J. C. I., & Feinberg, A. P. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.06.08.544045 · Cited by 4 · see citing works
Self-citationExpansion of the neocortex and protection from neurodegeneration by in vivo transient reprogrammingPreprint
Shen, Y., Zaballa, S., Bech, X., Sancho‐Balsells, A., Díaz-Cifuentes, C., Seyit-Bremer, G., Ballasch, I., Alcázar, N., Alberch, J., Abad, M., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.27.568858 · Cited by 4 · see citing works
Convergence of aging- and rejuvenation-related epigenetic alterations on PRC2 targets
Camacho, O. M., Koldobskiy, M. A., Reddy, P., Oak, A., Sun, Y., Sherman, K., Belmonte, J. C. I., & Feinberg, A. P. (2026) · Molecular Systems Biology · doi:10.1038/s44320-026-00195-9 · Cited by 8 · see citing works
Self-citationOhta, S., & Yamada, Y. (2023) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2023.102067 · Cited by 3 · see citing works
Le, N., Awad, S., Palazzo, I., Hoang, T. V., & Blackshaw, S. (2025) · eLife · doi:10.7554/elife.106450.2 · Cited by 3 · see citing works
Partial Cell Fate Transitions to Promote Cardiac Regeneration
Yang, J. (2024) · Cells · doi:10.3390/cells13232002 · Cited by 2 · see citing works
Mammalian Blastema: Possibility and Potentials
Nam, J., Min, B., Baek, A., Lee, S.-Y., Ha, J., Cho, M. J., & Kim, J. (2025) · International Journal of Stem Cells · doi:10.15283/ijsc24121 · Cited by 2 · see citing works
Cellular reprogramming beyond pluripotency
Nuñez-Quintela, V., Li, H., & Collado, M. (2026) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2026.01.007 · Cited by 2 · see citing works
- Authors
- Wang, C., Rabadan Ros, R., Martinez-Redondo, P., Ma, Z., Shi, L., Xue, Y., Guillen-Guillen, I., Huang, L., Hishida, T., Liao, H.-K., Nuñez Delicado, E., Rodriguez Esteban, C., Guillen-Garcia, P., Reddy, P., & Izpisua Belmonte, J. C.
- Affiliations
- Salk Institute for Biological Studies (US)
- ORCID
- Venue
- Nature Communications
- Published
- 2021-05-25
- Volume
- 12
- Issue
- 1
- Pages
- 3094-3094
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC8149870
- OpenAlex
- W3165546848
- Cited by
- 119
- References
- 55
- Citations by year
- 2026: 16 · 2025: 24 · 2024: 27 · 2023: 28 · 2022: 17 · 2021: 7
- FWCI
- 6.19
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Nature Communications (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- This work was supported by Asociación de Futbolistas Españoles (AFE), Fundacion Pedro Guillen, Universidad Católica San Antonio de Murcia (UCAM), The Glenn Foundation, The Moxie Foundation and CIRM
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Keywords
- partial reprogramming, Yamanaka factors, OSKM, muscle regeneration, satellite cells, muscle stem cells, stem cell niche, muscle fibers, Wnt4, p21, stem cell quiescence, aging cells, local gene expression
- MeSH terms
- Kruppel-Like Factor 4, Animals, Cell Differentiation, Cells, Cultured, Female, Mice, Transgenic, Myofibrils, Regeneration, Gene Expression, Proto-Oncogene Proteins c-myc, Satellite Cells, Skeletal Muscle, Octamer Transcription Factor-3, Kruppel-Like Transcription Factors, Stem Cell Niche, SOXB1 Transcription Factors, Wnt4 Protein, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-10.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-10.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review